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Abbreviations  
 
β -cells   Beta cells 
BM    Bone marrow  
BMSC    Bone marrow stem cells 
BSA     Bovine serum albumin  
bp     Base pair 
bHLH    basic helix-loop-helix 
cDNA     Complementary Deoxyribonucleic Acid 
Cy3     Cyanine-3-Tyramide 
DAPI    4', 6-Diamidino-2-phenylindole  
DMSO    Dimethyl sulfoxide 
DNA     Deoxyribonucleic acid  
dl     deciliter 
ECM    extracellular matrix 
ELISA    Enzyme-Linked Immunosorbent Assay 
EDTA     Ethylenediaminetetraacetic acid 
EGF    epidermal growth factor 
ESC     Embryonic stem cells  
FBS     Fetal Bovine Serum 
FITC     Fluorescein isothiocyanate 
g    Gram 
GLP 1    glucagon-like peptide 1 
GLUT –2   glucose transporter 2 
HBSS     Hank`s balanced salt solution  
hr     Hour 
HEPES                                    4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HGF                                        hepatocyte growth factor 
HNF                                        hepatocytes nuclear factor 
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HSC                                        Hematopoietic stem cells 
IAPP    Islet amyloid polypeptide 
IGF    insulin-like growth factor 
Isl-1     Islet-1 
kDa     Kilo Dalton 
l    liter 
M     Molar 
MODY   maturity-onset diabetes of young 
mRNA    messenger Ribonucleic Acid 
Min     Minute 
MSC    Mesenchymal stem cells 
µ     Micron  
N     Normal 
NGF    nerve growth factor 
NGN    neurogenin 
PBS    Phosphate buffered saline 
PCR     Polymerase chain reaction 
PDX1/IPF1                             pancreatic duodenal homeobox 1/insulin promoter factor 1 
PFA     Paraformaldehyde 
PP                                            pancreatic polypeptide 
RNA    Ribonucleic Acid  
RNase     Ribonuclease  
rpm    rounds per minute 
RT     Room temperature/reverse transcriptase 
s     Seconds 
SD     Standard deviation 
SDS-PAGE                             Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
TEM     Transmission electron microscopy  
TF     Transcription factor  
TSA     Trichostatin A  
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Summary 
 
Diabetes mellitus (DM) is a common metabolic disorder affecting millions of people 
worldwide and is characterized by abnormally high levels of glucose in blood. Type 1 
diabetes is caused by the destruction of pancreatic β-cells by T cells of the immune 
system. The common therapy of diabetes is daily injections of insulin. However, this 
therapy does not overcome the serious long-term complications that, result in overall 
shortened life expectancy of diabetic patients. Therefore, great efforts have been 
undertaken to develop novel strategies. A promising alternative to present treatments 
would be the generation and implantation of pancreatic islets from adult stem cells. 
 
Conditions were investigated that allow BM stem cells (BMSC) to differentiate into 
insulin-producing cells. A novel in vitro differentiation method was developed by using 
the histone deacetylase inhibitor (HDACi), Trichostatin A (TSA). BMSC, cultured in the 
presence of TSA. BMSCs differentiated into islet-like clusters under these culture 
conditions. These clusters were similar to the cells of the islets of the pancreas. The cells 
in the clusters showed endoderm specific gene expression typical for pancreatic β-cell 
development and function, such as insulin (I and II), glucagon, somatostatin, GLUT-2, 
pancreatic duodenal homeobox-1 (PDX-1), and Pax 4. To show that cells of the islet-like 
clusters synthesized pancreatic hormones, the co-localization of insulin and C-Peptide 
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was analyzed by immunocytochemistry. Enzyme-linked immunosorbent assay (ELISA) 
analysis demonstrated that insulin secretion was regulated by glucose concentration. 
Western blot analysis showed the presence of intracellular stored insulin. Electron 
microscopy of the islet-like cells revealed that they possessed an ultrastructure similar to 
that of pancreatic β-cells, which contain insulin granules within secretory vesicles. These 
findings suggest that histone-deacetylating agents help to promote differentiation of 
BMSC into functional insulin-producing β-cells. In addition, gene expression analysis 
confirmed the presence of new signaling pathways that are important in endocrine 
pancreas development. A subset of known and novel genes was temporally regulated, 
including genes that spatially define developing endocrine cells from BMSC. The 
development of new protocols to stimulate the differentiation of BMSC into pancreatic β-
like cells may contribute to future cell therapeutic treatments of type 1 diabetes.  
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1. Introduction  
 
A major source of energy for all cells is glucose, and all major food types are first 
broken-down to glucose prior to being used. Glucose is released from the gut into the 
blood stream, is taken up by cells in all tissues of the body, and is used as a fuel to 
generate energy that allows us to undertake all our major activities such as walking, 
running, and reading. Any excess sugar that is not used up immediately is stored in the 
cells as a backup source of energy. In healthy individuals, the level of circulating blood 
sugar is strictly regulated. This state of equilibrium, normoglycemia (normal glucose 
level), is tightly controlled by the hormone insulin, which is secreted in specific cells in 
the pancreas, the β-cells. This balance in glucose level is achieved through the regulation 
of the amount of insulin that is secreted to down-regulate increased blood sugar levels 
after consumption of sugar containing nutrients. 
1.1 Regulation of blood glucose 
Blood glucose levels are not always constant; they rise and fall depending upon the 
body´s needs and are regulated by hormones. This results in glucose levels normally 
ranging from 70 to 110 mg/dl. The blood glucose level can rise for three reasons: diet, 
breakdown of glycogen, or hepatic synthesis of glucose. Eating produces a rise in blood 
glucose, the extent of which depends on a number of factors such as the amount and the 
type of carbohydrate eaten (i.e., the glycemic index), the rate of digestion, and the rate of 
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absorption. Because glucose is a polar molecule, its absorption across the hydrophobic 
gut wall requires specialized glucose transporters (GLUTS).  
The liver releases glucose from the breakdown of glycogen and also synthesizes glucose 
from intermediates of carbohydrate, protein, and fat metabolism. The liver is a major 
regulator of glucose and can buffer blood glucose levels. It receives glucose-rich blood 
directly from the digestive tract via the portal vein. The portal vein drains almost all of 
the blood coming from the digestive tract and empties directly into the liver. The liver 
can quickly remove large amounts of glucose from the circulation so that even after a 
meal, blood glucose levels rarely rise above 110 mg/dl. 
The rise in blood glucose following a meal is detected by the pancreatic beta (β) cells, 
which respond by releasing insulin. Insulin increases the uptake and use of glucose by 
tissues such as skeletal muscle and fat cells. This rise in glucose also inhibits the release 
of glucagon, inhibiting the production of glucose from other sources, e.g., by glycogen 
breakdown. 
Once inside the cell, some of the glucose is used immediately via glycolysis. During the 
well-fed state, the high levels of insulin and low levels of glucagon stimulate glycolysis, 
which releases energy and produces carbohydrate intermediates that can be used in other 
metabolic pathways. Brain consumes more than 80% glucose. The liver and muscle take 
up any glucose that is not used immediately, where it can be converted into glycogen. 
Insulin stimulates glycogenesis in the liver by inducing hepatic glycogen synthetase (the 
enzyme that catalyzes glycogen synthesis in the liver). Insulin prevents the breakdown of 
stored glycogen (glycogenolysis) and the synthesis of new glucose (gluconeogenesis). 
Insulin also encourages glycogen formation in muscle, but by a different method. Here, it 
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increases the number of glucose transporters (GLUT4) on the cell surface. This leads to a 
rapid uptake of glucose that is converted into muscle glycogen. 
When glycogen stores are fully replenished, excess glucose is converted into fat in a 
process called lipogenesis. Glucose is converted into fatty acids that are further processed 
to triglycerides for storage. Insulin promotes lipogenesis by increasing the number of 
glucose transporters (GLUT4) expressed on the surface of the fat cell, causing a rapid 
uptake of glucose. In addition to promoting fat synthesis, insulin also inhibits fat 
breakdown by inhibiting hormone-sensitive lipase. As a result, levels of fatty acids in the 
blood stream decrease. Insulin also has an anabolic effect on protein metabolism. It 
stimulates both the entry of amino acids into cells and protein production from amino 
acids.  
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Figure 1.1 Mechanisms of glucose balance  
Under basal conditions, 80% of circulating glucose is taken up by the brain. When food is 
ingested, there is a parallel rise in blood glucose level (yellow arrow). This increase in blood 
glucose is sensed by the β-cells in the pancreas, and as a result, insulin is secreted (pale blue 
arrows). Insulin circulates through the body and signals to the major insulin sensitive organs 
(muscle, liver, and fat) to increase their glucose intake (red arrows). Insulin simultaneously leads 
to a reduction of glucose production from the liver and other organs (blue arrows). In this way, 
the hormone insulin counteracts the rise of glucose in the blood, thereby returning the system to 
its equilibrium. (This figure is adopted from Sanger Institute).  
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1.1.1 Role of Glucagon 
A drop in blood sugar levels inhibits insulin secretion and stimulates glucagon release. 
Glucagon opposes many actions of insulin. Most importantly, glucagon raises blood 
sugar levels by stimulating the mobilization of glycogen stores in the liver, providing a 
rapid burst of glucose. During continued fasting, glycogen stores are depleted under such 
conditions; glucagon stimulates glucose production by stimulating the hepatic uptake of 
amino acids, the carbon skeletons of which are used to synthesize glucose.  
1.2 Anatomy and functions of pancreas 
1.2.1 Anatomy   
The human pancreas is an elongated tapered organ lying behind the stomach and across 
the back of the abdomen. The pancreas is made up of two types of tissues: exocrine and 
endocrine tissue. The cells of the exocrine tissue secrete digestive enzymes into the 
digestive tract. These enzymes break down all categories of digestible foods. The 
endocrine pancreas produces hormones that affect carbohydrate metabolism. The 
endocrine tissue, which consists of the islets of Langerhans, secretes these hormones into 
the bloodstream. The islets of Langerhans contain insulin-producing β-cells (60–80% of 
the islet cells), glucagon-releasing alpha-cells (10-20%), somatostatin-secreting delta-
cells (3-10%), and a few pancreatic polypeptide-containing (PP) cells. Most of the 
insulin-containing cells occur in cell groups in the islets of Langerhans. The number and 
size of the pancreatic islets vary among species and seem to be regulated by 
developmental, nutrient, and hormonal factors. Pancreatic β-cells compose more than 
60% of the adult islet volume. Single islet β-cells rapidly and spontaneously reaggregate 
into spherical particles that can establish a mantle by associating with other islet 
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endocrine cells. This reaggregation of islet β-cells is thought to be calcium-dependent and 
stimulated by glucose and cyclic AMP. 
  
 
Figure.1.2 Schematic diagram of the anatomy of the pancreas  
The pancreas is located in the curve of duodenum. The exocrine pancreas contains acinar cells, 
whereas the endocrine pancreas contains four different populations of cells: alpha-cells, β-cells, 
delta-cells, and PP cells. (This figure is adopted from the website 
http://www.uchsc.edu/misc/diabetes/Chapter2C.ppt)  
 
1.2.2 General functions 
The pancreas has digestive and hormonal functions. The enzymes secreted by the 
exocrine tissue in the pancreas help to break down carbohydrates, fats, proteins, and acids 
in the duodenum. These enzymes travel down the pancreatic duct into the bile duct in an 
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inactive form. When they enter the duodenum, they are activated. The exocrine tissue 
also secretes bicarbonate to neutralize stomach acid in the duodenum. The hormones 
secreted by the endocrine tissue in the pancreas are insulin and glucagon (which regulate 
the level of glucose in the blood), and somatostatin (which prevents the release of the 
other two hormones). 
1.2.3 Functions of pancreatic β-cells 
The main function of pancreatic β-cells is the production and controlled release of 
insulin. The insulin gene is present as a single copy in all species, with the exception of 
rat and mouse, where there are two non-allelic insulin genes. The human insulin gene is 
located near the end of the short arm of chromosome 11 and is flanked on the 5´-side 
with the gene for tyrosine hydroxylase and on the 3´-side with the gene for IGF-II. The 
structure of the gene is highly conserved. 
Insulin is a small hormone composed of two polypeptide chains (A and B) linked by two 
disulfide bonds and has a molecular weight of about 6000 daltons. The A chain consists 
of 21 amino acids and the B chain of 30 amino acids. Insulin is a small protein and is 
produced as part of a larger protein to ensure it folds properly. In the protein assembly of 
insulin, the messenger RNA transcript is translated into an inactive protein called 
preproinsulin (Figure 1.3). Preproinsulin contains an amino terminal signal sequence that 
is required in order for the precursor hormone to pass through the membrane of the 
endoplasmic reticulum(ER) for post-translational processing. The post-translational 
processing clips away those portions not needed for the bioactive hormone. Upon 
entering  the ER, the preproinsulin signal sequence, now useless, is proteolytically 
removed from proinsulin. Once the post-translational formation of three vital disulfide 
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bonds occurs, specific peptidases cleave proinsulin. The final product of the biosyntheis 
is mature and active insulin. Finally, insulin is packaged and stored in secretory granules, 
which accumulate in the cytoplasm, until release is triggered.  
The secretory vesicles contain up to 80% of insulin related proteins. These are principally 
insulin and C-Peptide, both being present in equimolar amounts, and a much smaller 
amount of proinsulin and its intermediate conversion products. Insulin molecules are 
stored in crystalline form, occupying the electron-dense portion of the secretory granules. 
An adult pancreatic β-cell has a store of approximately 50 pg insulin per cell. Insulin 
molecules in storage granules are secreted by granule membrane fusion with the plasma 
membrane of the cell. Insulin molecules have a tendency to form dimers in solution 
because of hydrogen-bonding between the C-termini of the B chains. Additionally, in the 
presence of zinc ions, insulin dimers associate into hexamers. 
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Figure 1.3 Schematic representation of insulin synthesis 
Insulin production involved intermediate steps. Initially, preproinsulin is the inactive form that is 
secreted into the endoplasmic reticulum. Post-translational processing clips the N-terminal signal 
sequence and forms the disulfide bridges. Lastly, the polypeptide is clipped at two positions to 
release the intervening chain C. This and active insulin are finally packaged into secretory 
granules for storage. (This picture is adopted from Beta cell biology consortium) 
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1.2.4 Insulin secretion  
Increasing levels of glucose (above 10 mM) inside the pancreatic β-cells trigger the 
release of insulin.  However, insulin release is also induced by other factors, such as high 
amino acid and fatty acid levels in the blood, hormones released from the stomach and 
intestine, and neurotransmitters (Lang, 1999).  
Glucose is transported into the β-cell by type 2 glucose transporters (GLUT2). Once 
inside, the first step in glucose metabolism is the phosphorylation of glucose to produce 
glucose-6-phosphate. This step is catalyzed by glucokinase; this is the rate-limiting step 
in glycolysis, and it effectively traps glucose inside the cell. As glucose metabolism 
proceeds, ATP is produced in the mitochondria. The increase in the ATP:ADP ratio 
closes ATP-gated potassium channels in the β-cell membrane. Positively charged 
potassium ions (K+) are now prevented from leaving the β-cell. The rise in the positive 
charge inside the β-cell causes depolarization. Voltage-gated calcium channels open, 
allowing calcium ions (Ca2+) to flood into the cell. The increase in the intracellular 
calcium concentration triggers the secretion of insulin via exocytosis (Figure 1.4).  
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Figure 1.4 Schematic presentation of mechanism of insulin secretion  
Insulin secretion in beta cells is triggered by rising blood glucose levels. Starting with the uptake 
of glucose by the GLUT2 transporter, the glycolytic phosphorylation of glucose causes a rise in 
the ATP:ADP ratio. The rise inactivates the potassium channel that depolarizes the membrane, 
causing the calcium channel to open up allowing calcium ions to flow inward. The ensuing rise in 
levels of calcium leads to the exocytotic release of insulin from their storage granule. (This 
picture is adopted from Beta cell biology consortium.)  
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There are two phases of insulin release in response to a rise in glucose. The first is an 
immediate release of insulin. This is attributable to the release of preformed insulin, 
which is stored in secretory granules. Once depleted, a second phase of insulin release is 
initiated. This latter release is prolonged since insulin has to be synthesized, processed, 
and secreted for the duration of the increase of blood glucose. Furthermore, beta cells 
also have to regenerate the stores of insulin initially depleted in the fast response phase. 
As important as insulin is to preventing too high of a blood glucose level, it is just as 
important that there not be too much insulin and hypoglycemia. As one step in 
monitoring insulin levels, the enzyme insulinase (found in the liver and kidneys) breaks 
down blood-circulating insulin resulting in a half-life of about six minutes for the 
hormone. This degradative process ensures that levels of circulating insulin are 
modulated and that blood glucose levels do not get dangerously low.  
 
1.3 Pancreas organogenesis 
After gastrulation, mammalian endoderm, which is a sheet of undifferentiated cells, 
eventually forms the epithelial components of the gastrointestinal tract (esophagus, 
stomach, and intestine) and the glands derived from it (thyroid, thymus, pancreas, and 
liver) (Well et al., 1999). Pancreas arises from the endoderm as a dorsal and a ventral bud 
that fuse together to form a single organ (Slack, 1995).  
In mice, the pancreas begins to develop at embryonic day E9.5 from evaginations of the 
foregut endoderm at the level of the anterior intestinal portal (AIP), forming two 
primordia (dorsal and ventral) capped by mesenchymal cells (Pictet et al., 1972, Wells 
and Melton, 1999, Wessels and Cohen, 1967), which subsequently form a single gland at 
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around E13.5. This period of pancreatic organogenesis is called primary transition, 
referring to the changing of the pre-pancreatic endoderm (Edlund, 1999, 2000). 
Proliferation of the pancreatic epithelium results in the formation of branching cords from 
which clusters of endocrine and exocrine cells progressively differentiate (Herrera et al., 
1991, Slack, 1995). This differentiation wave occurs during the secondary transition, 
between E13.5 and E15.5 (Pictet and Rutter et al., 1972).  
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1.4 Genes and transcription factors involved in the development of pancreas 
The genes and transcription factors involved in the pancreas development were listed in 
Table 1. 
 
Table 1. Major pancreatic transcription factors; their expression and functions 
 
 
Transcription     Onset and site of    Mouse & human           References 
factor        pancreatic expression  mutations 
   
Homeodomain factors 
 
Pdx1   e8.5, early pancreatic   heterozygous human   Guz et al.,  
epithelium, beta and delta  mutation: MODY4  1995; Jonsson  
cells of mature pancreas Pancreatic agenesis,  et al., 1994; 
         Stoffers et  
al.1997a,b 
Ahlgren et al. 
1998;  
 
Pbx1  e10.5, ubiquitous   Hypoplastic pancreas    Kim et al.,  
 2002 
  
HNF6   e9.5, throughout the   Impaired endocrine      Jacquemin et  
pancreatic buds   differentiation    al.,2000 
   
Pax4   e9.5, in developing   Deficiency of beta &     Dohrmann et  
                        endocrine cells, not  delta cells, increase           al.,2000; Sosa-  
    found  in mature pancreas  in alpha cells       Pineda  et al.,  
1997 
 
Pax6          e9, in endocrine cells   No alpha cells, decrease  St-Onge et al.,  
in other endocrine   1997 
cell types 
 
Nkx2.2 e9.5, throughout pancreatic  Lack of beta cells, decrease  Sussel et. al,  
bud, later in endocrine cells  in alpha and PP cells  1998 
 
Nkx6.1  e9.5, in beta cells  Decrease in beta cells  Sander et al.,  
2000 
 
Isl1   e9, in all islet cells   No differentiated islet cells  Ahlgren et al.,  
1997 
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HNF1a e10.5, dorsal pancreas,  Heterozygous human   Nammo et al.,  
mature beta cells  mutation and homozygous 2002;  
mouse mutation: MODY3 Pontoglio et  
al., 1998 
 
HNF4a  e5.5, in visceral endoderm,  Early embryonic lethal  Ferrer, 2002; 
     e9.5 in pancreatic   Heterozygous human   Duncan et al., 
primordium   mutation: MODY1  1994 
 
Basic helix-loop-helix factors 
 
Ngn3   e9.5, endocrine precursors  No endocrine cells   Gradwohl et  
al., 2000; Gu 
et al., 2002 
 
NeuroD e9.5, endocrine precursors  Impaired islet    Jensen et al.,  
and adult islet cells   development   2000a; Naya  
et al., 1997 
 
Ptf1-p48 e10, exocrine, endocrine  No exocrine cells   Kawaguchi et  
and ductal progenitors     al., 2002; 
Krapp et al., 
1996; Krapp et 
al., 1998 
 
Forkhead / winged helix factors 
 
Foxa2 /  e5.5-6.5, early foregut  Lack of foregut   Lee et al.,  
HNF3b endoderm, adult acinar and  formation   2002; 
islet tissue        Sund et al.,  
2001 
 
Foxa1 /  e7.5, notochord, later in  Reduced proglucagon         Kaestner et al., 
HNF3a  all islet cell types  expression   1999 
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1.5 Pancreatic diseases 
A number of diseases relate to the pancreas. The most frequently occurring diseases are 
pancreatic carcinoma, pancreatitis (acute or chronic), pancreatic enzyme insufficiency 
and diabetes mellitus.  
Some 30,000 Americans are diagnosed with pancreatic cancer each year, and nearly all 
will succumb to the disease.  
Pancreatitis is a rapid and severe inflammation of pancreas; it can be acute or chronic. 
Binge alcohol drinking is a common cause of acute pancreatitis. Gallstones lodged in the 
main bile duct next to the pancreas also cause this condition. Accidents, such as the upper 
abdomen hitting the steering wheel during a car accident, can cause pancreatitis. Certain 
drugs, such as diuretics, can produce the disorder, as can extremely high blood fat levels 
(triglycerides). Heredity seems to play a role since, in some families; the condition 
develops in several members of the family. In pancreatitis, the digestive enzymes of the 
pancreas break out into the tissues of the organ rather than staying within the tubes 
(ducts). Severe damage to the pancreas then results.  
Pancreas enzyme insufficiency occurs when there is deficiency in the digestive enzymes 
that are necessary to break down protein, fat, and carbohydrates in foods that are 
ingested. The nutrients are not broken down, resulting in malnutrition and weight loss. 
This condition is also called malabsorption because the intestine is unable to absorb these 
vital nutrients. 
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1.6 Diabetes mellitus 
According to the World Health Organization in 2006, at least 171 million people 
worldwide suffer from diabetes. Diabetes mellitus is characterized by abnormally high 
levels of glucose in blood. This may be because of the inadequate secretion or action of 
insulin, an inadequate response by the body’s cells to insulin, or a combination of all 
these factors. The most common forms of diabetes are type 1 and type 2 diabetes. 
Gestational diabetes occurs at the time of pregnancy, and other forms of diabetes are rare 
and are caused by a single gene mutation.  
 
 
Figure 1.5 Epideomology of diabetes 
Number of persons with diabetes in the year 2000 and estimated for the year 2030. (This figure is 
adopted from Yach et al., 2006.) 
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1.6.1 Type 1 diabetes 
Type 1 diabetes affects 700,000 people in the United States and is the most common 
chronic metabolic disorder to affect children. Type 1 diabetes (10% of cases) is caused by 
autoimmune destruction of β-cells of the islets of Langerhans resulting in absolute insulin 
deficiency. The gene thought to be responsible for this reaction is located within a region 
of the major histocompatibility complex (MHC) HLA class 2 gene, called IDDM1. The 
role of this gene in the immune response is the presentation of foreign molecules to T 
cells; however, the detailed action of the gene is still under investigation. The onset is 
usually acute, the disease developing over a period of a few days to weeks. Over 95% of 
persons with type 1 diabetes mellitus develop the disease before the age of 25, with an 
equal incidence in both sexes. 
1.6.2 Type 2 diabetes 
An important factor in type 2 diabetes is the body´s resistance to insulin, and another 
factor is the falling production of insulin by the β-cells of pancreas. Thus, type 2 diabetes 
may be a combination of the deficient secretion and deficient action of insulin. Defective 
β-cells become exhausted, further fueling the cycle of glucose intolerance and 
hyperglycemia. This is the most common form of diabetes mellitus, and the etiology is 
multifactorial. It is highly associated with a family history of diabetes, older age, obesity, 
and lack of exercise. Type 2 diabetes accounts for 90-95% of all cases of diabetes. The 
prevalence of type 2 diabetes is increasing dramatically across the globe and in some 
areas has reached epidemic proportions. This increase in prevalence is primarily being 
driven by environmental factors, through “modern age” dietary and exercise habits.  
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1.7 Pathology of diabetes 
People with diabetes are vulnerable to a variety of complications over time. Control of 
blood sugar is the best way to minimize the risk of complications. However, even the best 
control may not be able to eliminate all complications, and the risk of side effects 
increase with time.  
1.7.1 Short-term acute complications 
In the absence of either the secretion or action of insulin, the blood glucose concentration 
rises quickly (hyperglycemia) after glucose or carbohydrate intake. As a result, the 
amount of glucose that is filtered into the kidney tubules increases. The capacity for the 
kidney to reabsorb glucose from the urine is limited. If the amount of glucose that enters 
the tubules is too high (i.e., if it exceeds the glucose threshold), glucose appears in the 
urine. This condition is termed glucosuria. Because of osmotic effects, glucose in the 
urine draws with it considerable amounts of water, which will be excreted along with the 
glucose. As a result, urine volume and frequency increases (polyuria) and the diabetic 
individual are frequently dehydrated and nearly always thirsty (polydipsia).  
In type 1 diabetics, the unopposed actions of glucagon result in increased ketone 
formation by the liver. These ketones are acidic, and their build up considerably lowers 
blood pH and disturbs the acid/base balance of the body. This condition is termed 
ketoacidosis and is the most frequent cause of death amongst diabetics under the age of 
30. When ketones reach high enough concentrations in the blood, they are excreted out 
with the urine. Ketones carry cations, such as sodium (Na+) and potassium (K+), with 
them into the urine leading to electrolyte imbalances in the body. Consequences of these 
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complications may include abdominal pain, vomiting, sweet-smelling breath, and severe 
dehydration. Severe cases can lead to diabetic coma and death. 
1.7.2 Long-term chronic complications 
Several secondary complications usually accompany long-standing diabetes mellitus. 
These often involve gradual changes that develop over a period of years and may shorten 
the life expectancy of diabetic individuals. The most common involve the damage of 
blood vessels. In diabetes, the resultant problems are grouped under “microvascular 
disease” (caused by damage to small blood vessels) and “macrovascular disease” (caused 
by damage to the arteries).  
1.7.3 Microvascular disease 
The damage to small blood vessels leads to microangiopathy, which causes organ-related 
problems. Lesions in the small blood vessels and capillaries supplying the retina of the 
eye lead to diabetic retinopathy. Every year thousands of diabetics become blind as a 
result. Abnormal and decreased sensation, usually progressive, starting at the feet but 
potentially in other nerves called as diabetic neuropathy. Combined with damage in blood 
vessels, this can lead to diabetic foot. Other forms of diabetic neuropathy may present as 
mononeuritis or autonomic neuropathy. Damage to the kidney, which can lead to chronic 
renal failure, eventually requiring dialysis also known as diabetic nephropathy. Diabetes 
is the most common cause of adult kidney failure worldwide. 
1.7.4 Macrovascular disease 
Macrovascular disease leads to cardiovascular disease, mainly by accelerating 
atherosclerosis. Coronary artery disease can lead to myocardial infarction (“heart attack”) 
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or angina. Diabetes can also cause stroke (mainly ischemic type) and diabetic 
myonecrosis. 
Long-term microvascular and neurologic complications cause major morbidity and 
mortality in patients with insulin-dependent diabetes mellitus. Careful maintenance of 
blood concentrations close to the normal range can decrease the frequency and severity of 
these complications.  
 
1.8 Treatment of diabetes mellitus  
1.8.1 Treatment for type 1 diabetes Type 1 diabetes can only be treated with insulin 
injections. Previously, cadavers and animal pancreas products were the primary sources. 
Both sources posed a risk of allergenic reactions, because insulin had to be purified from 
a complex mixture of proteins. There was also a potential for the transmission of disease, 
particularly viruses and especially of unknown viruses. Today, diabetics receive insulin, a 
recombinant protein produced in bacteria (Escherichia coli). Human insulin produced by 
recombinant technology has replaced bovine and porcine insulin preparations. The 
commonly available human insulins represent groups of short-, intermediate-, and long-
acting insulins and biphasic mixtures. All groups have different characteristics with 
respect to the onset and duration of action. DNA recombination technologies provide the 
opportunity for the creation of insulin analogs with improved function. One group 
represents rapid-acting analogs known also as “rapid-onset” and “ultra-short-acting” 
insulins and includes insulin aspart and insulin lispro. Both recombinants contain 
modifications in the amino acid sequence of the insulin B chain. The advantage of using 
these analogs is a faster response in comparison with conventional short-acting insulin; 
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therefore, they can be injected immediately before meals or even after eating and are 
useful for young patients. The disadvantage of the rapid-acting analogs is the relatively 
short duration of insulin action. Another group of recombinant insulins are long-acting 
analogs that include insulin glargine (created by substitution and adding amino acids) and 
insulin detemir (created by adding a fatty acid chain to enhance binding to albumin). The 
advantage of the long-acting analogs is the more reproducible absorption and reduced 
risk of hypoglycemia (UBS Warburg Report, 2001). 
1.8.2 Treatment of type 2 diabetes Type 2 diabetes patients has a wider range of 
treatment options in comparison with type 1 diabetes. Treatment of type 2 diabetes 
includes lifestyle modifications and the application of oral hypoglycemic agents or 
eventually insulin injections. Diet and exercise help type 2 diabetics to control their blood 
glucose, blood pressure, and blood lipid levels. Five groups of oral hypoglycemic agents 
are used in the treatment of type 2 diabetes: sulphonylureas, alpha-glucosidase inhibitors, 
prandial glucose regulators, glitazones (thiazolidinediones), and biguanides (UBS 
Warburg Report, 2001). Often a combination of different anti-diabetic drugs is used to 
increase the efficiency of therapy.  
1.8.3 Side effects:  
Hypoglycemia, or abnormally low blood glucose, is a complication of several diabetes 
treatments. It may develop if the glucose intake does not match the treatment. The patient 
may become agitated and sweaty and have many symptoms of sympathetic activation of 
the autonomic nervous system resulting in feelings similar to dread and immobilized 
panic. Consciousness can be altered, or even lost in extreme cases, leading to coma 
and/or seizures or even brain damage and death. In patients with diabetes, this can be 
Introduction                                                                                              31 
 
caused by several factors, such as too much or incorrectly timed insulin, too much 
exercise or incorrectly timed exercise (which decreases insulin requirements), or not 
enough food, or an insufficient amount of carbohydrates in food. In most cases, 
hypoglycemia is treated with sweet drinks or comestibles. In severe cases, an injection of 
glucagon (a hormone with the opposite effects of insulin) or an intravenous infusion of 
glucose is used for treatment, but usually only if the diabetic is unconscious.  
Patients may experience blurred vision if they have had elevated blood sugar levels for a 
prolonged period of time and then have the elevated levels rapidly brought to normal. 
This is attributable to a shift of fluid within the lens of the eye. Over time, vision returns 
to normal. Other possible side effects that may occur include skin reactions (redness, 
swelling, itching or rash at the site of injection), worsening of diabetic retinopathy, 
allergic reactions, sodium retention, and general body swelling. 
 
1.9 Strategies to cure diabetes 
Currently, there is no permanent cure for diabetes. People with type 1 diabetes must take 
insulin several times a day and test their blood glucose concentration three to four times a 
day. Frequent monitoring is important because patients who keep their blood glucose 
concentrations as close to normal as possible can significantly reduce many of the 
complications of diabetes, such as diabetic retinopathy and heart disease that tend to 
develop over time. People with type 2 diabetes can often control their blood glucose 
concentrations through a combination of diet, exercise, and oral medication. 
Transplantation of whole pancreas or islet cells is the best method at present for curing 
type 1 diabetes.   
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1.9.1 Transplantation of islets and whole pancreas 
The most promising therapeutic option for the treatment of type 1 diabetes is the 
transplantation of insulin-producing cells. Several different cell sources are considered as 
successful replacement therapies. Transplantation of the whole pancreas or pancreatic 
islets can result in insulin independence, but problems related to graft rejections are 
reasons for the low efficiency of this therapy (Brendel et al., 1999). Islet allografts 
usually mismatch for at least one MHC antigen. Therefore, without immunosuppression, 
these allografts are rejected. Transplantation of new insulin-producing β-cells, in the form 
of the whole pancreas or isolated islets, in combination with a specific glucocorticoid-
free immunosuppression regime (Edmonton protocol, Shapiro et al., 2000), has been 
shown to ameliorate the disease by eliminating the need for exogenous insulin and 
normalizing glycosylated hemoglobin levels (Shapiro et al., 2003; Kaufman and Lowe et 
al., 2003; Ricordi et al., 2003; Titus et al., 2000). However, freshly isolated islets from at 
least two immunologically compatible donors are necessary for the successful 
transplantation of adequate amounts of tissue. Because the number of human donors is 
limited, wide scale application of this therapy is not possible.  
Use of xenogenic tissue, such as porcine islets, is an alternative option, but use of strong 
immunosuppressive drugs and the risk of retroviral infections create barriers for clinical 
applications (Butler, 1998). Therefore, other cell sources must be considered with respect 
to the generation of transplantable insulin-producing cells for a therapy of diabetes. 
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1.9.2 Transplantation of insulin-secreting cell lines 
Insulin-expressing cell lines such as β-cell lines derived from insulinomas could represent 
an unlimited, easily available source of insulin-producing cells (Miyazaki et al., 1990, 
Dufayet de la Tour et al., 2001, Itkin-Ansari.P et al., 2001, Narushima et al 2005). Many 
different cell types including fibroblasts, muscle cells, keratinocytes, and hepatocytes 
have been transfected with the insulin gene. Unfortunately, most of the engineered non-β-
cells produce and secrete only small amounts of insulin, and the insulin release is not 
adequately controlled by glucose levels. Despite strict selection procedures, the risk of 
tumorigenesis remains because of the possibility of epigenetic changes, chromosomal 
instability, or mutation during the culture of the immortalized cells.   
1.9.3 Pancreatic progenitors as a source of islet cells 
Pancreatic ductal epithelium, through sequential steps of differentiation, gives rise to all 
pancreatic endocrine cell types (Hellerstrom et al., 1984; Slack, 1995). There is clear 
evidence for the existence of pancreatic stem/progenitor cells in the ductal epithelium 
(Bonner-Weir and Sharma, 2002). The cultivation of mouse pancreatic epithelium under 
appropriate conditions results in the differentiation of functional endocrine cells secreting 
insulin in a glucose-dependent manner and the normalization of high blood glucose levels 
after implantation into diabetic mice (Ramiya et al., 2000). Similar results have been 
reported for human pancreatic ductal epithelial cells (Bonner-Weir et al., 2000; Gao et 
al., 2003). Exocrine tissue contains cells that can differentiate toward a pancreatic 
endocrine phenotype (Lipsett et al., 2002). 
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1.9.4 Embryonic stem (ES) cells as a source for islet cells 
Stem cells are defined by their ability both to self-renew and to differentiate into 
specialized cells (Czyz et al., 2003). ESC have a virtually unlimited proliferation capacity 
and can differentiate into derivatives of nearly all lineages (Hoffman et al., 2005, Liew et 
al., 2005). Pluripotent ESC represent potentially unlimited source of pancreatic cells for 
regenerative therapies. However, so far, current techniques do not allow the generation of 
pure populations of somatic cells from ESC.  
ESC could be cultivated and directed to differentiate into the insulin-producing islet cells 
of the pancreas. Insulin-secreting cells derived from ESC in vitro release insulin upon 
glucose induction (Soria et al., 2001) and are able to normalize glycemia in 
streptozotocin-induced diabetic mice (Soria et al., 2000). Under non-selective culture 
conditions, a small subpopulation of ESC spontaneously differentiates into pancreatic 
endocrine cells (Shiroi et al., 2002, Kahan et al., 2003). Islet like-clusters show regulated 
insulin release in vitro but fail to normalize high blood glucose levels in animal models 
(Lumelsky et al., 2000, 2001). Addition of growth inhibitors, cytokines, manipulation of 
the culture conditions and the use of transcription factors associated with the β-cell 
lineage (Hori et al., 2002, Kania et al., 2003, Kahan et al., 2003, Stoffel et al., 2004, 
Blyszczuk et al., 2003 and Miyazaki et al., 2004), have yielded promising results. Human 
ESC differentiate into insulin-producing cells under various culture conditions (Assady et 
al., 2001, Segev et al., 2004, Schuldiner et al., 2000, Yan Shi et al., 2005). Although the 
differentiated ESC are insulin-positive, insulin mRNA is inconsistently detectable and 
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weak, and C-Peptide and secretory granules have not been detected (Rajagopal et al., 
2003). 
Major obstacles remain to be overcome before insulin-producing cells derived in this way 
can be used therapeutically; typically, there is a mixed population of cells with only the 
minority producing insulin, the insulin content per cell is lower than that in adult human 
β-cells, the regulation of secretion is not fully physiological, the differentiated ESC 
survive poorly, and most studies have depended on mouse ESC.  
1.9.5 Generation of islet-like cells from adult stem and progenitor cells 
There are many attempts to derive insulin-producing cells from adult stem cells. 
Transplantation of splenocytes regenerate insulin-producing cells (Ryu et al., 2001, 
Kodama et al., 2003), recently Nishio et al., 2006, showed there is no evidence of 
splenocytes regenerate into insulin-producing cells. Liver oval cells have been 
transdifferentiated into glucose-responding insulin-producing cells (Yang et al., 2002, 
Zalzman et al., 2003). Adult intestinal epithelium after treatment with glucagon-like 
peptide-1 (GLP-1) develop into glucose-responsive insulin-producing cells, which after 
transplantation into diabetic mice reverse experimentally induced diabetes (Suzuki et al., 
2003). In rodents, hemopoietic organs harbor cells that can also differentiate into 
functional pancreatic endocrine cells. (Ianus et al., 2003, Hess et al., 2003, Zorina et al., 
2003, Ryu et al., 2001, kodama et al., 2003, Kofman et al., 2004). BM cells can 
differentiate in vitro under controlled conditions into insulin-expressing cells (Jiang et al., 
2002, Jahr et al., 2003). Such cells transplanted under the kidney capsule of diabetic 
animals have been demonstrated to regulate glucose levels in the blood (Dong-Qi Tang et 
al., 2004). However, recent reports also showed that the so-called, trans-differentiation 
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capacity of adult stem cells is rather limited (kirchhof et al., 2002), could not be repeated 
(Morshead et al., 2002, Wagers et al., 2002), or may be the result of cell fusions with 
endogenious cells (Alvarez-Dolado et al., 2003, Terada et al., 2002). Therefore, further 
detailed studies are needed to solve these questions.  
 
1.10 Adult stem cells 
An adult stem (AS) cell is an undifferentiated cell found among differentiated cells in 
somatic tissues or organ systems. AS cells are known to maintain and regenerate/repair 
tissues and organ systems and have been found in tissues characterized by extensive 
regeneration such as bone marrow (BM) (De Haan et al., 2002), skin (Watt et al., 2001), 
intestinal epithelium (Potten et al., 1998), and liver (Theise et al., 1999).  
Hematopoietic stem cells (HSCs) in BM provide a continuous source of progenitors for 
red cells, platelets, monocytes, granulocytes, and lymphocytes (Hay et al., 1966), because 
circulating blood cells survive for only a few days or months. BM stromal cells or 
mesenchymal stem cells (MSC) can give rise to osteocytes, chondrocytes, adipocytes, 
and tenocytes (Pittenger et al., 1999). Neural stem cells in the brain can differentiate into 
its three major cell types: neurons, astrocytes, and oligodendrocytes (Copray et al., 2006). 
Intestinal epithelial stem cells in the lining of the digestive tract give rise to absorptive 
cells, goblet cells, Paneth cells, and enteroendocrine cells (Quinlan et al., 2006). 
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1.10.1 Transdifferentiation   
AS cells can be differentiated into cells not normally associated with their “committed” 
state (Fuchs et al., 2000). This property is known as transdifferentiation or plasticity.  
Several reports have shown that hematopoietic stem cells from BM develop into neural, 
myogenic, and hepatic cell types, and neural or skeletal muscle stem cells develop into 
the hematopoietic lineage (Bjornson et al., 1997, Clarke et al., 2000, Fuchs et al., 2000, 
Galli et al, 2000, Gussoni et al., 1999, Jackson et al., 1999, Petersen et al., 1999). BMSC 
differentiate into cardio-myocytes (Fukuda et al., 2003), whereas mesenchymal stem cells 
develop into adipocytic, chondrocytic, or osteocytic lineages (Pittenger et al., 1999).  
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Figure 1.6 Transdifferentiation of adult stem cells.  BM cells can differentiate into liver 
cells and skeletal muscle cells. BMSC can differentiate into cardiac muscle cells, neurons, 
epithelial cells, and skeletal muscle cells. Brain stem cells can differentiate into blood cells. (This 
figure is adapted from the website http://stemcells.nih.gov/info/basics/basics4.) 
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1.11 Chromatin remodeling of stem cells  
The key goal of stem cell research is to attain an understanding of the manner in which 
differentiation is controlled and the direction that cellular differentiation will take. This 
should result in a better appreciation of stem cell biology and allow the optimal use of 
these cells in cell therapy.  
Stem cell differentiation was controlled by both intrinsic regulators and the extracellular 
environment (niche). Under appropriate conditions in cell culture, stem cells can 
differentiate spontaneously. However, spontaneous differentiation is generally inefficient 
and leads to a heterogeneous population of differentiated and undifferentiated cells, 
which are not useful for cell-based therapy and also complicate biological studies of 
particular differentiation programs. Thus, stem cell expansion and differentiation ex vivo 
are generally controlled by “cocktails”of growth factors, signalling molecules, and/or 
genetic manipulation. Clearly, more efficient and selective methods are needed to direct 
the proliferation and the differentiation of stem cells, in order to produce homogeneous 
populations of particular cell types. This may not only be essential for the therapeutic use 
of stem cells, but will also greatly facilitate studies of the molecular mechanisms of 
development. 
Actual stem cell fate decision might be governed by the expression patterns of 
transcription factors that may be under the control of methylation and deacetylation of 
chromatin, whereas commitment or differentiation might be triggered and regulated by 
external regulatory pathways, being activated by interactions of BM cells with growth 
factors or cytokines or the marrow microenvironment. Once these gene expression 
Introduction                                                                                              40 
 
patterns are known, small molecules might be identified that would favour their 
activation leading to the in vitro maintenance or expansion of not only BM stem cells but 
also possibly stem cells belonging to a variety of other somatic tissues.  
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2. Aim of the study 
 
The major goal of this work was to define a protocol, required for the development of a 
cell therapy for diabetes in a mouse model.   
1. The development of a reproducible culture protocol for generating insulin-producing 
cells by using bone marrow stem cells. 
2. The evaluation of the contribution of chromatin reprogramming to the in vitro 
differentiation of BM cells, with the use of the chromatin remodeling factors TSA, 
azacytidine, sodium butyrate and DMSO. 
3. The histological evaluation of differentiated cells for the expression of pancreas- 
specific hormones. 
4. The analysis of endocrine pancreas-specfic transcription factors and genes during 
development. 
5. The functional analysis of differentiated cells, specifically with respect to glucose-
regulated insulin release.  
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3. Material and Methods  
 
3.1 Chromatin remodeling factors 
3.1.1 Trichostatin A 
Molecular Formula: C17H22N2O3
Formula weight: 302.4 Dalton  
Trichostatin A (TSA; 4, 6-dimethyl-7-[p-dimethyl-aminophenyl]-7-oxohepta-2,4-
dienohydroxamic acid) is an inhibitor of histone deacetylase (HDAC; including the 
mammalian form), isolated from Streptomyces. It serves as an antifungal antibiotic and 
inhibits the eukaryotic cell cycle at the beginning of the growth stage. TSA can be used to 
alter gene expression by interfering with the removal of acetyl groups from histones and 
therefore alters the ability of DNA transcription factors to access the DNA molecules 
inside chromosomes. Thus, TSA has uses as an anti-cancer drug. By promoting the 
expression of apoptosis-related genes, it may lead to cancerous cells surviving at lower 
rates, thus slowing the progression of cancer.  
3.1.2 Dimethyl sulfoxide (DMSO) 
Molecular Formula: C2H6OS 
DMSO is an amphipathic molecule and is one of the most commonly used chemicals in 
the biological and medical sciences as a solvent for water-insoluble substances and a 
cryopreservant for various cell lines including ES and adult stem cells. It has multiple 
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effects on cellular functions such as metabolism and enzymatic activity and on cell 
growth by affecting cell cycle and apoptosis (Trubiani et al., 1999). It also changes cell 
fates by inducing the differentiation of various types of cells (Geder et al., 1987, Oh et 
al., 2004). Moreover, DMSO effects DNA methylation status (Iwatani et al., 2006). 
3.1.3 Sodium butyrate 
Molecular formula: CH3CH2CH2COONa. 
Formula Weight: 110.09 Dalton 
Sodium butyrate, an HDAC inhibitor, significantly enhances survival and reduces both 
neuropathological effects and motor deficits in R6/2 transgenic mouse models. Sodium 
butyrate and similar HDAC inhibitors are currently being tested as anticancer drugs 
because of their inhibitory effects on cell proliferation (Kuefer et al., 2004). Sodium 
butyrate/retinoic acid co-stimulation induces apoptosis-independent growth arrest and 
cell differentiation (Buommino et al., 2000).  
3.1.4 Azacytidine 
Molecular formula: C8H12N4O5
5-Azacytidine or 5-aza-2´-deoxycytidine is a chemical analog of cytosine nucleoside 
present in DNA and RNA. Cells in the presence of 5-azacytidne incorporate it into DNA 
during replication and into RNA during transcription. The incorporation of 5-azacytidine 
into DNA or RNA inhibits methyltransferase thereby causing demethylation in that 
sequence and affecting the way that cell regulation proteins are able to bind to the 
DNA/RNA substrate. It is also used in the treatment of myelodysplastic syndrome.  
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3.2 Mice 
Female mice (6-10 weeks old, C57BL/6) were purchased from Harlan (HARLAN 
WINKELMANN GmbH, Borchen, Deutschland, www.harlan-winkelmann.de) and 
maintained in a specific pathogen-free facility until used. Mice were treated in 
accordance with institute guidelines. 
 
3.3 Isolation of mouse bone marrow cells 
Mice were sacrificed by cervical dislocation. Bone marrow (BM) was flushed out from 
the tibias and femurs of C57BL/6 mice with Dulbecco’s modification of Eagle’s liquid 
medium (DMEM; ICN) in the presence of 10% fetal bovine serum (FBS) by using a 27 
Gauge needle. Cells were pelleted after centrifugation at 800 rpm for 10 min at room 
temperature (RT), the supernatant was discarded, and the pellet was resuspended in an 
appropriate volume of medium. 
 
3.4 Culturing and differentiation of BM stem cells  
The BM cells were plated at a density of 1 x 106 cells/cm2 in 6-well plates in normal 
DMEM containing 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, and 100 
U/ml glutamine and allowed to adhere to the cell culture plate. After 12 hrs of incubation, 
nonadherent cells were washed out with fresh serum-free DMEM. The cells were treated 
with TSA/butyrate/azacytidine/DMSO (kindly donated by Prof. Dr. Jürgen Bode, GBF, 
Braunschweig) at 55 nm/ml in serum-free DMEM for 3 days. For the induction of 
differentiation, chromatin remodeling factors were withdrawn from the medium, and the 
cells were then cultured for an additional 7 days in specific induction medium containing 
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a 1:1 ratio of DMEM:DMEM/F12 (GIBCO) supplemented with 10% FBS and 10 nm/ml 
glucagon-like peptide–1 (Glp-1), in the presence of high (25mM) glucose. The medium 
was changed every 2 days according to the cell requirements. 
 
3.5 Isolation of pancreatic islets 
Pancreatic islets from mice were isolated according to a previously described method 
with a few modifications (Gotoh et al., 1985). Briefly, 6- to 10-week-old female 
C57BL/6 mice were killed by cervical dislocation. The pancreata were removed, without 
ductal injection or distention, cut into small pieces, and washed three times with ice-cold 
Hank´s balanced salt solution (HBSS), (GibcoBRL, Life Technologies, Cat. No.14185-
045) in order to remove released trypsin. The resulting pieces were suspended in 5 ml 
HBSS, containing 2,500 U collagenase Type 2 (Worthington Biochemical Corporation, 
Cat. No. 9001-12-1) and digested with shaking at 37°C for 30 min. The digested sample 
was washed three times with cold HBSS. The pellet was suspended in 10 ml 25% Ficoll 
solution (1.084 g/ml); the three uppermost layers consisted of 5 ml 23% (density 
1.077g/ml), 5 ml 20% (density 1.068g/ml), and 5 ml 11%( density 1.038g/ml) Ficoll 
solution, respectively. Islet purification was performed by centrifugation at 800 g for 15 
min at 4°C. Islets were harvested from the interfaces of the 11% and 20%, 20% and 23%, 
and 23% and 25% Ficoll solutions and washed with cold HBSS. Islet cell viability was 
confirmed by trypan blue exclusion. 
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3.6 Dithizone staining  
Abbreviation: DTZ (Merck; Whitehouse Station, NJ) 
Chemical Formula: C13H12N4S 
IUPAC Name: Anilinoimino-phenylazo-methanethiol 
Preparation of stock solution: Dissolve 50 mg Dithizone in 5 ml DMSO. Store at –
20°C until used. 
Preparation of working solution: Bring stock solution to RT. Filter using 0.2 µm nylon 
filters. 
Staining method: Remove excess medium from the tissue culture plate containing 
differentiated BM cells. Add 10 µl working DTZ solution to the 1 ml culture medium. 
Incubate the tissue culture plate at 37°C for 30 min in DTZ solution. Rinse the cells three 
times with HBSS. Observe the crimson-red-stained clusters under a stereomicroscope 
(Zeiss Axiovert S100). After examination, refill the tissue culture plate with DMEM 
containing 10% FBS. Stain completely disappears after 5 hrs of incubation with DMEM 
containing 10% FBS. 
 
3.7 Newport Green DCF labeling 
Abbreviation: NG 
NG is an ester (diacetate form, NG-Ac; Molecular Probes Europe; Leiden, The 
Netherlands). 
Molecular formula: C43H30Cl2N4O8
Molecular weight: 801.64 
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Principle: The ester form (NG-Ac) was used for fluorescence studies on living cells. 
NG-Ac is cell-permeant and therefore diffuses across cell membranes. Once inside the 
cells, this ester is cleaved by intracellular esterases to yield a cell-impermeant fluorescent 
indicator able to bind to zinc. The NG indicator exhibits an increase in fluorescence 
emission on binding to Zn, with a slight shift in wavelength; single excitation and 
emission spectral peaks were measured at wavelengths of 485 and 530 nm, respectively. 
Method of labeling: Differentiated BM cells cultured in Tissue Tek chambered slides 
washed with phosphate-buffered saline (PBS) three times. Cells in PBS were exposed for 
30 min at 37°C to 25 mM NG-Ac containing 1.5 µl/ml Pluronic F127 (Molecular Probes) 
to enhance the penetration of the probe. Cells were rinsed with PBS thrice and  analyzed 
using confocal microscope. 
 
3.8 Immunocytochemistry 
Immunofluorescence analysis allows the investigation and characterization of BM cell 
differentiation in terms of the proteins expressed, at both the intracellular (e.g., 
intermediate-filament proteins) and extracellular (e.g., cell-surface antigens) levels. The 
method is especially valuable in BM cell differentiation studies, because differentiation 
of stem cells often results in a heterogeneous population. Immunofluorescence allows the 
detection of even a small minority of antigen-positive cells against a largely negative 
background. Two methods fixation were used (i) methanol:acetone (suitable for 
cytoskeletal proteins, such as intermediate filaments) and (ii) paraformaldehyde (suitable 
for intracellular proteins).  
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Reagents and equipment 
Paraformaldehyde fixation solution: 0.4 g paraformaldehyde and 10 ml PBS mixture 
heated at 60°C; stirred until the solution becomes clear, and then cooled to RT (prepare 
shortly before use). 
Preparation of 10% serum solution: 1 ml heat-inactivated serum mixed in 9 ml of PBS 
and store at 4°C. (Do not use serum from the same species as has been used for the 
preparation of the primary antibody).   
Preparation of sodium citrate buffer: 
(10 mM sodium citrate, 0.05% Tween 20, pH 6.0): 
 
Tri-sodium citrate (dihydrate)   2.94 g 
Distilled water      1,000 ml 
2.94 g of Tri-sodium citrate was dissolved in 1000 ml distilled water completely. pH was 
adjusted to 6.0 with 1 N HCl and then 0.5 ml Tween 20 was added and mixed well. 
Sodium citrate buffer was stored at RT for 3 months or at 4°C for longer storage. 
DAPI (4,6-diamidino-2-phenylindole) solution (Sigma): 1:500 dilution was prepared in 
PBS and stored in the dark at 4°C. 
Fluorescence or Confocal microscope: The model LSM META510 confocal scanning 
laser system, including an Axiovert 200 M microscope (Carl Zeiss, Germany). 
Fixation of differentiated cells: Cells cultured in Tissue Tek chamber slides (for 
immunocytochemistry) were fixed with 4% paraformaldehyde for 20 min at RT.  
Staining differentiated cells: The fixed cells in Tissue Tek chambered slides were 
washed with PBS, three times. The cells were permeabilized with Triton-X 100 (1%) for 
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5 min (10 ml PBS+100 µl Triton-X 100) and then rinsed (2x3 min) with PBS. Cell 
membrane was polarized with 0.1% glycine for 5 min (100 mg glycine in 100 ml PBS) 
then washed (2x3 min) with PBS. To prevent unspecific binding, cells were incubated 
with 10% serum solution (apply ~100 µl overlay per chamber, in a chambered slide) in a 
humidified chamber at RT for 30 min. 60-100 µl of the primary antibody was prepared by 
dilution in PBS (the optimal dilution of each antibody was determined separately). Cells 
with the primary antibody were incubated in a humidified chamber at 4°C overnight. 
Cells were gently washed three times with PBS. 100 µl of the secondary fluorescence-
conjugated antibody was prepared by dilution in PBS (the optimal dilution for each was 
determined separately). Cells were incubated with 100µl secondary antibody at 37°C in a 
humidified chamber for 45 min. Chambered slides were rinsed three times with PBS at 
RT. Cells on chambered slides were incubated with 200 µl DAPI solution for counter-
staining the nuclei, in a humidified chamber at 37°C for 10 min. Chambered slides were 
rinsed three times with PBS at RT. Chambered slides were mounted on a clean slide by 
using mounting medium (Merck-Kaiser´s glycerol gelatin, which contains phenol; Lot 
no. 1.09242.0100) and analyzed by using a fluorescence or confocal microscope (Prmary 
antibodies, secondary antibodies, isotype controls used in the study were listed in Tables 
3.1, 3.2, 3.3 respectively). 
Staining of paraffin sections: Paraffin-embedded tissue sections were deparaffinized in 
two changes of xylene for 4 min each. Hydrated in two changes of 100% ethanol for 4 
min each, followed by changes in 95% and 80% ethanol for 2 min each. Then rinsed in 
distilled water for 2 min. In a water bath, a staining dish was pre-heated containing 
sodium citrate buffer until the temperature reaches 98°C. Slides were immersed in the 
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staining dish and incubated for 60 min. The staining dish was removed from water bath 
and allowed the slides to cool for 20 min. The tissue sections were rinsed in washing 
buffer (2x2 min). The sections were blocked with normal serum-blocking solution for 
30 min at RT. Serum was removed from sections carefully, taking care not to dry the 
section. Primary antibody was added at the appropriate dilution and incubated overnight 
at 4°C. Sections were rinsed in washing buffer (3x5 min). Secondary antibody was added 
and incubated for 1 hr at RT and then rinsed with washing buffer (3x5 min). Counter-
stained with DAPI for 10 min and rinsed again with washing buffer three times. Mounted 
with mounting medium.  
Staining cryo sections: Sections were brought to RT for 20-30 min. Sections were fixed 
with methanol (100%) at 4°C for 3 min and subsequently in acetone (100%) for 3 min at 
4°C. Air-dried for 1 hr and rinsed with PBS for 10 min. The remaining steps were 
common for fixed cells and tissue sections-permeabilization, antibody incubation, and 
mounting techniques.  
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Table 3.1 List of primary antibodies  
 
Antibody   Antigen   Company    Host 
 
Insulin (H-86):    aa 25-110   Santa Cruz Biotech  Rabbit 
sc-9168 
Insulin A (C-12):  C-terminus   Santa Cruz Biotech  Goat 
sc-7839    of Insulin A chain 
 
C-Peptide serum  Purified synthetic LINCO Research  Goat  
Cat. No. 4023-01 
 
Glucagon (C-18):  C- terminus  Santa Cruz Biotech   Goat 
sc-7779 
 
Somatostatin                               aa1-116                          Santa Cruz Biotech                      Rabbit  
sc-20999    
             
PDX 1 (N-18)                N- terminus                    Santa Cruz Biotech         Goat 
sc-14662  
NGN3                                          Fusion protein               Prof. Michael S. German             Rabbit 
                                                                                           UCSF, California 
Pax 6(H-295)                 aa 264-422 C-terminus    Santa Cruz Biotech                    Rabbit            
sc-11357 
 
 
 
Table 3.2 List of secondary antibodies  
Antibody             Antigen              Conjugate                  Company                 Host 
 
 
Goat Ig G  Whole molecule        Cy3      Sigma           Rabbit 
(C 2821) 
Rabbit Ig G        (H+L)                      Alexa Fluor 488          Molecular probes     Goat 
Rabbit IgG         F(ab´)2 Fragment       Cy3                            Sigma                       Sheep 
(C 2306)  
Rabbit IgG         (H+L)                       Alexa Fluor 488        Molecular probes       Donkey 
(A21206) 
Goat IgG-R        Whole molecule       Rhodamine                Santa Cruz                 Donkey  
(sc-2094)  
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Table 3.3 Isotype controls  
 
Antibody                      Antigen                             Company                                 Host 
 
 
Rabbit IgG                    Fc fragment            Jackson Immuno Research            Goat 
(111-001-008) 
 
Goat IgG       Serum                    Nordic immunological labs          Rabbit 
 
 
 
3.8.1 Confocal microscopy 
Immuno-labeled cell preparations were examined by fluorescence microscopy. Wherever 
possible, a confocal laser-scanning microscope (CLSM) was used instead of a 
conventional fluorescence microscope, as confocal images were considered to be 
superior. Furthermore, confocal microscopy allowed the co-localization of proteins, 
which was especially relevant to the three-dimensional structures that were observed 
with, for example, BM-derived pancreatic cells. 
Confocal imaging was performed with an LSM META510 confocal scanning laser 
system on an Axiovert 200 M microscope (Carl Zeiss, Jena, Germany). The instrument 
settings are given below. Images were obtained with a Plan-Neofluar 40x/1.3 oil-
immersion objective lens. 
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Table 3.4 Parameters and settings for confocal microscopy 
 
     Para- 
          meters 
 
 
Fluorescent 
dye  
Lasers Excition 
wavelength 
(nm) 
Emission filter 
 
(nm) 
Detector 
Alexa 
488/FITC 
Argon 
(max.7%) 
488 BP505-530 normal 
Alexa 
546/Texas 
Red/Cy3 
 
HeNe1 
(max.20%) 
543 BP 560-615 normal 
DAPI Enterprise UV  
(max.14%) 
364 BP 475-525 normal 
 
3.9 Three-dimensional (3D) reconstruction image of differentiated cluster  
The 3D projection and reconstruction were performed with the Projection in 3D view 
menu (projection method: transparent; rotation: along Y-axis) using LSM software. 
Stack size: 
X: 115.2 µm 
Y: 115.2 µm 
Z:  14.0 µm 
Slice interval: ½ µm 
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3.10 ELISA 
The enzyme-linked immunosorbent assay (ELISA) is a common immunoassay used for 
the detection and quantification of a substance based on immunological reactions. ELISA 
is a valuable tool because the technique is highly sensitive and specific and allows rapid 
and simultaneous processing of a large number of samples. This method was suitable for 
the quantification of secreted insulin from BM cell culture systems. 
Equipment and reagents 
Krebs Ringer Bicarbonate Hepes (KRBH) buffer composition: 118 mM sodium 
chloride, 4.7 mM 
potassium chloride, 1.1 mM potassium dihydrogen phosphate, 25 mM sodium hydrogen 
carbonate, 3.4 mM calcium chloride, 2.5 mM magnesium sulphate, 10 mM Hepes, and 2 
mg/ml bovine serum albumin. 
Other reagents: D (+)-Glucose monohydrate (Cat. No. 1.08346.1000, Merck, Germany), 
DMEM (with 4.5 g/l glucose, Invitrogen), fetal calf serum (FCS; Gibco BRL, Cat. No. 
011-06920), trypsin-EDTA solution (0.5% / 0.2% (w/v), ultrasensitive mouse insulin 
ELISA kit (Mercodia, Cat. No. 10-1150-01), Protein Bradford Assay (Bio-Rad 
Laboratories, Cat. No. 500-0006). 
3.10.1 Quantification of secreted insulin: Medium was aspirated from 12-well tissue-
culture plates containing BM-derived pancreatic islet-like cells and rinsed the cultures 
three times with 3 ml PBS. PBS was replaced with freshly prepared KRBH buffer 
supplemented with 3.8 mM glucose and incubated for 120 min at 37°C. KRBH buffer 
supplemented with 3.8 mM glucose was aspirated. KRBH buffer supplemented with 
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either 7 mM glucose, 12 mM glucose, or 27.7 mM glucose and 10 µM tolbutamide 
(Sigma) was added to separate tissue culture plates and incubated for 180 min at 37°C. 
Supernatant was collected and stored at –20°C for determination of insulin release. 
Secreted insulin assay procedure: Each determination was performed in duplicates for 
calibrators and unknowns. A calibration curve was prepared for each assay run. All 
reagents and samples were brought to RT before use. Calibrators used were 0, 0.025 µg/l, 
0.063 µg/l, 0.22 µg/l, 0.60 µg/l, and 1.5 µg/l. Unknown samples were added in triplicates. 
50 µl-enzyme conjugate was added to calibrators and unknown samples and incubated on 
shaker for 2 hrs at RT. After incubation plate was washed 6 times, and the reaction 
volume aspirated. 350 µl wash buffer was added to each well, then aspirated completely, 
repeated 5 times. After the final wash, the plate was inverted and tapped firmly against 
absorbent paper. Substrate TMB (3,3′,5,5′-tetramethylbenzidine) (200 µl) was added to 
each well and incubated for 30 min on shaker. Stop solution (50 µl) was added to each 
well. Plate was kept on shaker for approximately 5 sec for ensuring proper mixing of 
substrate and stop solution. The absorbance was measured at 450 nm and evaluated.  
 
3.11 Intracellular insulin detection: Sufficient amount of trypsin-EDTA solution 
was added to cover the whole surface and incubated at RT for 2-3 min. Trypsin-EDTA 
solution was removed carefully and added 3 ml DMEM medium supplemented with 10% 
FBS. Cells were resuspended with a 2 ml glass pipette and transferred to 15 ml tubes and 
centrifuged for 5 min at 1,000 g at RT. Supernatant was aspirated, lysis buffer was added, 
then transferred to 1.5 ml tubes, and freeze-thawed in liquid nitrogen to break open the 
cell wall of the cells. Then centrifuged for 5 min at 13,000 g at RT. Supernatant was 
transferred to new 1.5 ml tubes and stored at –20°C for determination of intracellular 
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total protein and insulin levels. Secreted insulin level with ELISA and total protein 
content by using the Bradford assay were determined according to the manufacturer’s 
recommendations.  
3.11.1 Co-immunoprecipitation (Co-i.p) 
Cell pellet was prepared by pippeting or by mechanically using a cell scraper. Cell pellet 
was freeze-thawed in liquid nitrogen to break open the cell wall and stored at –20°C, until 
processed. The pellet was thawed, 200 µl lysis buffer was added containing protease 
inhibitor and phosphatase inhibitor. All the steps were carried out on ice. The cells were 
lysed and the preparation was passed into labeled Eppendorf (eppi) vials. Then the vials 
were centrifuged at 14,000 rpm at 4°C for 10 min. The supernatant was collected into a 
new eppi vial. 10 µl supernatant was taken into 50 µl of 2x SDS buffer and stored at –
20°C. Anti-insulin antibody (1.65 µg) was added to the supernatant and incubated this 
mixture at 4°C on a rotating wheel for 2 hrs. After incubation, all the solution was 
brought to the base of the eppi vial by quick spinning. The sepharose beads were 
prepared by taking 300 µl orginal suspension of protein G – Sepharose 4 FF (Pharmacia, 
in 20 % ethanol) in 1.5 ml eppi vials. Beads were washed three times with 1 ml lysis 
buffer without protease and phosphatase inhibitor. 50 % of original suspension was 
resuspended in lysis buffer. 25 µl sepharose beads were added to each sample. Then 
bead/solution mixture was incubated for 1 hr at 4°C on the rotation wheel. After 
incubation, centrifuged them at 2,000 rpm for 2 min. The beads were washed seven times 
by using co-i.p buffer with protease inhibitor and phosphatase inhibitor, then resuspended 
in 20 µl 2x SDS without β-mercaptoethanol and stored at – 20°C. 
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3.11.2 Western blot 
Cell lysis: For 1 ml RIPA buffer, 1 µl protease inhibitor was added. Scraped cells were 
added into 200 µl RIPA buffer, cells were lysed by vortexing. The lysed cells were kept 
on ice for 30 min, and then centrifuged at 10,000 rpm, and the supernatant was collected 
for protein estimation. 
RIPA buffer composition:  
60 ml                   10x PBS 
6   ml             Igapal 
3 gm                   Sodium deoxycholate 
0.6 gm             SDS 
 
Made up to 600 ml with double-distilled water (DDH2O) 
SDS-Polyacrylamide gel electrophoresis 
Separating gel (15%): 
ddH2O   3.6 ml 
1.5 M Tris, PH -8.8    3.75 ml 
Acrylamide (30:0.8)    7.5 ml 
10% APS     100 µl 
TEMED     10 µl 
Stacking Gel: 
ddH2O                 3.47 ml 
1 M Tris, PH-6.8    625 µl 
Acrylamide     850 µl 
10% APS     50 µl 
TEMED     5 µl 
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Method: The protein samples were resolved by gel electrophoresis. The transfer of the 
proteins was fractioned by SDS, was performed by using a semi-dry electroblotting 
system onto a nitrocellulose membrane. The membrane was blocked for 1 hr at RT, 
incubated with rabbit anti-insulin antibody (1:5,000) overnight at 4oC, washed in Tris-
buffered saline-Tween (3x5 min each), and incubated with anti-rabbit horseradish 
peroxidase (1:10,000) for 1 hr at RT. The washing buffer was removed, and the 
membrane was prepared for chemiluminescence by using an ECL kit.  
 
3.12 RNA extraction  
Total cellular RNA was extracted from whole BM and differentiated cells by using 
TRIzol® (GIBCO/BRL). RNA extraction was performed as follows. 
Samples were brought to RT. 133 µl 1-bromo-3-chloropropane (BCP) (Merck-
Schuchardt) was added for every 1 ml sample. Centrifuged for 15 sec and waited for 10 
min then centrifuged for 30 min, at 12,000 relative centrifugal force (rcf), at 7°C. Upper 
phase was collected carefully, without contaminating the middle or lower phases, into a 
fresh 1.5 ml eppi vial. Ice-cold isopropanol was added (slightly greater volume than that 
of the supernatant). All these steps were performed on ice. Samples were incubated at –
70°C for 1 hr or use a prolonged incubation period of up to 2 days. The pellets were 
stored at –20°C. The samples were brought to RT. Immediately centrifuged for 30 min, at 
12,000 rcf, at 7°C. Pellet were washed with 1 ml 75% ethanol for 20 min at 12,000 rcf. 
The pellets were dried at RT or at 37°C on a heater. The samples were dissolved in 7 µl 
water treated with diethylpyrocarbonate (DEPC water). Samples Kept at 55°C on a heater 
for 10 min. Centrifuged quickly, without opening the lid. 2 µl sample was taken a to 
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check the quality and quantity of RNA on a gel and by absorption. All samples were 
stored at –70°C. 
 
3.13 Reverse transcritpion/polymerase chain reaction (RT PCR) 
One criterion for establishing the successful differentiation of BM cells into pancreas 
cells in vitro is the expression of genes that are normally involved in pancreas 
development in vivo. 
Reverse Transcription: 
 
Reagents:  
 
DEPC water 
RNase inhibitor (Promega) 
dNTP  (Invitrogen) 
Oligo dT primer (Invitrogen)  
M-MLV reverse transcriptase (Promega) 
 
Method: 2 µg RNA was taken for each sample in sterile tubes for (+) and (-) RT 
reactions.1 µl oligo dT primer was added and made this preparation to 15 µl with DEPC 
water. Incubated for 5 min at 70°C, immediately placed on ice for 5 min, and then 24 µl 
reaction mix (see below) was added. A sufficient volume of the following (+)/(-) RT 
master reaction mixtures were prepared for all reaction tubes. 
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RT master reaction mixture  
DEPC-water  13.4µl 
MLV buffer  5.0µl  
dNTP´s  5.0 µl  
RNAsin  0.6 µl 
Total volume  = 24.0 µl 
 
The samples were incubated for 2 min at 42°C, immediately 1 µl reverse transcriptase 
was added to the (+) RT samples, incubated for 1 hr at 42°C and then for 5 min at 95°C 
to denature reverse transcriptase. 
PCR: 
Reagents: 
Fast Start Taq DNA Polymerase (Roche)  
PCR buffer (Roche) 
Forward primer, 10 µM (Invitrogen) 
Reverse primer, 10 µM (Invitrogen) 
dNTP, 25 µM (Invitrogen) 
DEPC water 
Method: An aliquot of 1 µl each cDNA sample was taken into a sterile PCR tube. A 
sufficient volume of the PCR master reaction mixture was prepared for all reaction tubes 
and then 24 µl of this mixture was added to each tube.  
PCR master reaction mixture 
PCR buffer    2.5 µl 
dNTP     0.5 µl  
Forward primer   0.62 µl 
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Reverse primer   0.62 µl  
Taq DNA polymerase   0.2 µl  
DEPC water    19.55 µl  
Total volume    = 23.99µl 
 
PCR cycling conditions  
Cycles  Temp. (°C)  Time 
 
1  95  4 min 
     95  30 min 
35  xa  30 min 
72  1 min 
1  72  10 min 
 
ax is the annealing temperature dependent on the primer used. 
The PCR products were stored at 4°C. These PCR products were checked on 2% agarose 
gel.  
The oligonucleotide sequences specific for the selected genes involved in the 
development and function of pancreatic beta cells were presented in (Table 3.5).  
Table 3.5 Primers for PCR 
 
Gene Primer sequence Length 
of gene
Annealing 
temperature
No.of 
cycles
Glut2 5´ACAGAGCTACAATGCAACGTGG 
5´CAACCAGAATGCCAATGACGAT 
221 bp 53 35 
IAPP 5’-TGATATTGCTGCCTCGGACC 
5’-GGAGGACTGGACCAAGGTTG 
233 bp 65 35 
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Isl-1 5’-GTTTGTACGGGATCAAATGC 
5’-ATGCTGCGTTTCTTGTCCTT 
514 bp 50.2 35 
Ngn3 5’-TGGCGCCTCATCCCTTGGATG 
5’-AGTCACCCACTTCTGCTTCG 
157 bp 60 35 
Pax4 5´ACCAGAGCTTGCACTGGACT 
5´CCCATTTCAGCTTCTCTTGC 
236 bp 62 35 
Pdx1 5´TGGATAAGGGAATTGCTTAACCT 
5´TTGGAACGCTCAAGTTTGTA 
582 bp 53 35 
Hnf3β 5´AGAAGCAACTGGCACTGAAGGA 
5´GTAGTGCATGACCTGTTCGTAG 
464 bp 60 35 
Proinsulin I 5´GTTGGTGCACTTCCTACCCCTG 
5´GTAGAGGGAGCAGATGCTGGTG 
300 bp 60 35 
Proinsulin II 5´GTGGATGCGCTTCCTGCCCCTG 
5´GTAGAGGGAGCAGATGCTGGTG 
300 bp 60 35 
Glucagon 5´CACTCACAGGGCACATTCACC 
5´ACCAGCCACGCAATGAATTCCTT 
221 bp 52 35 
Pancreatic 
polypeptide 
5´CTGCCTCTCCCTGTTTCTC 
5´GGCTGAAGACAAGAGAGGC 
337 bp 52 35 
Somatostatin 5´GACCTGCGAACTAGACTGAC 
5´TTTGGGGGAGAGGGATCAG 
294 bp 52.2 35 
M-Sur1 5´CCAGACCAAGGGAAGATTCA 
5´GTCCTGTAGGATGATGGACA 
236 bp 53 35 
β-Actin 5´GTCGTCGACAACGGCTCCGGCATG 
TG 
5´CATTGTAGAAGGTGTGGTGCCAGATC
220 bp 55 35 
 
3.14 Electron microscopy  
For post-embedding detection of insulin in differentiated cells, samples were fixed with 
0.2% glutaraldehyde and 0.5% formaldehyde for 1 hr on ice, washed with PBS 
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containing 10 mM glycine, and dehydrated in a graded series of ethanol following the 
progressive lowering of temperature protocol (PLT method). Samples were then 
embedded in Lowicryl K4M (Polysciences, Inc, Warrington, USA, Cat. No. 15923) at –
35°C and polymerized with UV-light (366 nm, 2 days at –35°C, 2 days at RT). Ultra-thin 
sections were cut with glass knives and collected onto formvar-coated copper grids (300 
mesh). Sections were incubated with a rabbit polyclonal anti-insulin antibody (sc-9168, 
Santa Cruz biotechnology; 100 µg IgG protein/ml) overnight at 4°C, washed with PBS, 
and incubated with gold markers (protein A/G gold, 15 nm in diameter from Bio cell 
Cardiff, UK) for 30 min at RT. After being washed with PBS containing 0.01% Triton X-
100 and in distilled water, samples were air-dried. Counterstaining was carried out with 
4% uranyl acetate for 1 min. Samples were then examined in a Zeiss transmission 
electron microscope EM910 (Zeiss, Oberkochen, Germany) at an acceleration voltage of 
80 kV. 
 
3.15 Nuclear imaging  
Three-dimensional stacks of fixed cells were acquired with the Leica TCS SP2 confocal 
laser scanning microscopy (CLSM) (Leica Microsystems, Mannheim, Germany) using a 
63x/1.32 NA oil immersion objective. A diode and an Argon laser were used for DAPI 
(λ=405 nm). For the analysis of the reversibility of the TSA-induced accessibility 
changes, BM cells without treatment were imaged before and again after TSA treatment 
with DAPI nuclear staining. For DAPI imaging, excitation was carried out with a laser 
diode at 405 nm, and emission was recorded at 420-480nm.  
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3.16 Microarray analysis 
3.16.1 RNA isolation  
Total RNA was isolated by using the Qiagen RNeasy column kit (Cat.No. 74104). 
Briefly, BM cells and differentiated cells at day 3 and day 10 were lysed with an 
appropriate volume of Qiagen RLT buffer. The samples were then homogenized, 
centrifuged with an equal volume of 70% ethanol, washed with Qiagen RW1 buffer for 
15 sec, incubated with Dnase I for 15 min at RT, and washed sequentially with Qiagen 
RW1 and Qiagen RPE buffers. The RNA was eluted with 30 µl Rnase-free water and 
stored at –20°C until processed further.  
3.16.2 DNA microarray hybridization 
The quality and integrity of the isolated total RNA was checked by running all samples 
on 2100 Bioanalyzer (Agilent Technologies; Waldbronn, Germany). For biotin-labeled 
target synthesis starting from 3 µg total RNA, reactions were performed by using 
standard protocols supplied by the manufacturer (Affymetrix; Santa Clara, CA). Briefly, 
3 µg total RNA was converted to double-stranded DNA by using 100 pmol T7T23V 
primer (Eurogentec; Seraing, Belgium) containing a T7 promotor. The cDNA was then 
employed directly in an in vitro transcription reaction in the presence of biotinylated 
nucleotides.  
The concentration of biotin-labeled cRNA was determined by UV absorbance. In all 
cases, 12.5 µg each biotinylated cRNA preparation was fragmented and placed in 
hybridization cocktail containing four biotinylated hybridization controls (BioB, BioC, 
BioD, and Cre) as recommended by the manufacturer. Samples were hybridized to an 
identical lot of Affymetrix GeneChips for 16 hrs.After hybridization, the GeneChips were 
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washed, stained with Streptavaidin Phycoerythrin (SAPE) solution and read on an 
Affymetrix GeneChip fluidic station and scanner. 
 
3.16.3 Data analysis 
Microarray data was analyzed by using the Affymetrix GCOS 1.2 and Data Mining Tool 
3.1 software package. For normalization, all array experiments were scaled to target 
intensity of 150 or by using the default values of GCOS 1.2. The results were filtered. 
 
3.17 Sources of chemicals      
Chemical       Company   
Acetone                                                                      Baker B.V., Deventer, Holland  
Antibodies      Santa Cruz Biotechnologies 
Collagenase Type 2                                                   Worthington 
DAPI                                                                          Sigma-Aldrich GmbH, Deisenhofen 
DMSO                                                               Sigma-Aldrich GmbH, Deisenhofen 
EDTA                                                                        Sigma-Aldrich GmbH, Deisenhofen 
Embedding medium OCT                                          Leica GmbH, Bensheim 
Fetal bovine serum (FBS)         Invitrogen 
Gelatine                                                                      Sigma-Aldrich GmbH, Deisenhofen 
Glycin                                                                        Merck KG, Darmstadt 
Glycerin gelatine, Kaisers                                          Merck KG, Darmstadt          
HBSS        Sigma-Aldrich GmbH, Deisenhofen 
H2SO4                                                                                                       Sigma-Aldrich GmbH, Deisenhofen 
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Laminin      Sigma-Aldrich GmbH, Deisenhofen 
NaCl                                                                      Merck KG, Darmstadt 
Paraformaldehyde                                          Sigma-Aldrich GmbH, Deisenhofen  
QIAquick PCR Purification Kit                                 Qiagen GmbH, Hilden 
Rneasy Kit                                                                  Qiagen GmbH, Hilden 
Triton X-100                                                              Sigma-Aldrich GmbH, Deisenhofen    
Tris-HCl                                                                     Sigma-Aldrich GmbH, Deisenhofen 
Trizma Base                  Sigma-Aldrich GmbH, Deisenhofen                                 
Trypan blue                                                                Gibco Life Technologies GmbH 
Trypsin                                                             Gibco Life Technologies GmbH  
Tween 20                                                                   Sigma-Aldrich GmbH, Deisenhofen         
Culture Media 
Dulbeccos Minimal Essential Medium (DMEM)   Sigma-Aldrich GmbH, Deisenhofen         
DMEM/Ham F12      Invitrogen 
 
3.18 Statistical analysis  
All values are given as means±standard error of the mean. When data between two 
groups were compared, an unpaired or paired Student’s t – test was used. P<0.05 was 
considered to be statistically significant for all comparisons.  
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4. Results 
 
4.1 Chromatin remodeling factors induce differentiation of bone marrow 
cells 
To evaluate the effect of chromatin remodeling factors on the differentiation of bone 
marrow (BM) cells into insulin-producing cells, the cells were treated with 55 nM TSA, 
24 µM azacytidine, 5 mM butyrate, or 1% DMSO. Murine BM cells were isolated, plated 
in 6-well tissue culture plates, and cultured in the presence of chromatin remodeling 
factors for 3 days and then maintained for an additional 7 days in differentiation 
induction medium containing 10 nm Glp-1 and high glucose (25 mM). After removal of 
TSA, cells cultured in the high glucose medium started to form spheroid-like cell clusters 
from day 5, attaining their maximum size and maximal number at day 10. This did not 
occur in control BM cells cultured in the absence of both TSA and high glucose (Fig 
4.1.1A). Cells cultured in the presence of TSA for 3 days exhibited normal cell 
morphology (Fig 4.1.1B). The three-dimensional cellular morphology of the subsequently 
formed cell aggregations closely resembled pancreatic islet-like clusters (Fig 4.1.1C, 
4.1.1D), as previously described (Ramiya et al., 2000, Yang et al., 2002). The islet-like 
clusters contain well defiened edges and structure.  As many as 300 to 350 clusters 
formed per well of 6-well culture plates. The cellular morphology indicated that BM cells 
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could differentiate into islet-like cells in the presence of TSA followed by high glucose 
culture. 
The results of the experimental approach by using various chromatin remodeling factors 
inducing pancreatic islet-like clusters are summarized in (Fig 4.1.2). Sodium butyrate 
showed a similar effect to that of TSA but with fewer numbers of islet-like clusters being 
formed. Azacytidine was cytotoxic at higher concentrations but, at micromolar 
concentrations, was effective on BM cells, resulting in the formation of islet-like clusters. 
However, the number of clusters was relatively low. The number of cellular clusters 
obtained after treatment with sodium butyrate (200-250), azacytidine (150-200), or 
DMSO (around 300), and with TSA (300 to 350). Murine BMSC after treatment with 
sodium butyrate, azacytidine and DMSO differentiated into islet-like clusters, but with 
lower efficiency compared with TSA.    
Expression of pancreas specific genes and transcription factors involved in the 
development of pancreas were evaluated by RT-PCR analysis. The culture treated with 
various chromating remodeling factors and cultured in high glucose medium, expressed 
transcripts of insulin genes I and II and of transcription factors Isl 1, Pax4, Hnf3β (Fig 
4.1.3) after 10 days. Positive control was not shown in this figure, but it was presented in 
the figure with TSA treatment. All treatments stimulated the expression of pancreas 
specific genes. 
As BM cells treated with TSA and subsequently cultured in the presence of high glucose 
showed a higher number and larger size of three-dimensional spheroid clusters in 
comparison with those seen after treatment with other chemicals, all further work was 
carried out with TSA.  
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Figure 4.1.1 Chromatin-remodeling factor (TSA) induces bone marrow (BM) cells to 
differentiate into islet-like cell clusters 
 (A) BMSC cultured for 10 days in normal DMEM. BMSC were treated in serum-free medium 
for 3 days with histone deacetylase inhibitor TSA and then cultured in 10% FBS, GLP-1, and 
high glucose (25mM) for an additional 7 days. (B) BMSC cultured for 3 days in the presence of 
TSA. (C) BMSC cultured for 3 days in the presence of TSA and subsequently for an additional 7 
days in high glucose medium, formed islet-like clusters (10x), at higher magnification (D), (40x). 
Scale bar for (A), (B), (C) 100 µm and (D) 50 µm 
 
 
 
 
 
Results                                                                                                     70 
 
 
 
 
A B
C 
Figure 4.1.2 Formation of islet-like clusters after treatment with various chromatin 
remodeling agents.  
BMSC were treated with chromatin remodeling factors for 3 days and then cultured in 10% FBS, 
GLP-1, and high glucose (25mM) for an additional 7 days formed islet-like clusters. After sodium 
butyrate treatment (A), Azacytidine treatment (B) and DMSO  treatment, (C) (40x) BMSC 
differentiated into islet-like clusters. Scale bar for (A), (B), (C) 50 µm.  
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Figure 4.1.3 Expression of pancreas specific genes after differentiation. 
After treatment with chromatin remodeling factors BMSC cultured in presence of high glucose 
for addition 7 days were analyzed for pancreas specific genes and transcription factors using RT-
PCR.. Lane 1. Trichostatin A (TSA), Lane 2. Sodium butyrate, Lane 3. Azacytidine, Lane 4. 
DMSO 
 
4.2 Detection of insulin containing cells in islet-like clusters  
Zinc is required by pancreatic beta cells (β-cells) for the packaging of insulin, and free 
ionized zinc is present in the extra-granular space as a reservoir for granular zinc and 
forms an integral part of insulin crystals in the 2-Zn-insulin hexamer. We took advantage 
of these zinc pools to identify cells carrying out insulin synthesis in our cultures. The 
differentiated cells in cultures were stained with the zinc-chelating agent DTZ, and with 
the zinc-dependent fluorescent indicator Newport Green (NG-Ac). 
We first determined whether isolated pancreatic islets from mouse were stained with 
DTZ and found that most of the islet cells did indeed stain crimson red. Differentiated 
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BMSC cells and, more specially, cells in the islet-like clusters exhibited distinct crimson 
red staining with DTZ (Fig 4.2A). Most of the crimson red stained cells are present in the 
core of islet-like cluster.  Undifferentiated BMSC, cultured for 10 days in normal 
medium were not stained (Fig 4.2B). 
In pancreatic β-cells insulin is packaged and stored in secretory granules, which 
accumulate in the cytoplasm. NG-Ac ester stains living cells, on enzymatic cleavage by 
cellular esterases, by binding to Zn2+. Green fluorescent dots were seen in confocal 
images of differentiated cells stained with NG-Ac (Fig 4.2C). Individual cells revealed a 
heterogeneous intensity of fluorescence with cytoplasmic dots, suggesting the presence of 
insulin in secretory granules.  The control BMSC cultures did not show significant 
staining with NG-Ac (Fig 4.2D). No nuclear staining was noted. Since insulin is expected 
to accumulate specifically in cytoplasm, this shows that there is no detectable non-
specific staining.  
These results indicate the presence of zinc in viable differentiated cells. The presence of 
cells positive for zinc-specific dyes such as DTZ and NG-Ac therefore suggested that 
insulin-producing cells could be derived from BM stem cells.  
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Figure 4.2 Detection of insulin-containing cells in islet-like clusters   
Cells in islet-like clusters were stained with zinc-chelating agents, DTZ and Newport Green (NG-
Ac). (A) Day 10: Cells distinctly stained crimson-red by DTZ are apparent in the differentiated 
islet-like clusters. (B) Undifferentiated BM cells (C) Individual differentiated cells stained with 
NG-Ac (D) Control cells for the NG-Ac stain. Scale bar for (A), (B) 20 µm and for (C), (D) 10 
µm. 
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4.3 Detection of pancreas-specific hormones 
To investigate the possible expression of pancreatic hormones in the cultured BM cells, 
immunofluorescence analysis was performed for insulin, C-Peptide, glucagon, and 
somatostatin. Immunostaining of the individual islet-like clusters, which were formed in 
BM cell cultures treated with TSA and subsequently cultured under high-glucose 
conditions, revealed large numbers of insulin-positive cells. Double-immunofluorescence 
analysis showed insulin (Fig 4.3.1A, left), C-Peptide (Fig 4.3.1A, middle), and co-
labeling (Fig 4.3.1A, right) in the same cells of the islet-like clusters. Cells were 
counterstained by DAPI to reveal nuclei (Fig 4.3.1A). The co-localization of C-Peptide 
demonstrated the de novo insulin synthesis and excluded that cells only absorbed and 
concentrated insulin from the medium. Glucagon- and somatostatin-expressing cells were 
also present in the culture. The staining for glucagon was found in the periphery of the 
cell (Fig 4.3.1B), whereas somatostatin was dispersed in the cytoplasm (Fig 4.3.1C). Co-
staining for insulin (Fig 4.3.1D, left) and somatostatin (Fig 3.3.1D, middle) showed that 
somatostatin-expressing cells were fewer in number than insulin-expressing cells in 
culture (Fig 4.3.1D, right). Transcription factor neurogenin 3 (Ngn3) was distinctly 
present in the nucleus of the differentiated islet-like cells (Fig 4.3.1E, middle and right). 
Matched isotype controls for rabbit IgG (Fig 4.3.1F) and goat IgG (Fig 4.3.1G) and 
without primary antibody (Fig 4.3.1H) served as negative controls. These results 
indicated that (1) differentiated BM cells synthesized insulin de novo as indicated by the 
presence of C-Peptide; similar to pancreatic β-cells. (2) other pancreatic-hormone-
producing cells were also present in the culture after 10 days, interestingly higher number 
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of insulin expressing cells and (3) the transcription factor Ngn3 was expressed by the 
islet-like cells. Adult mouse pancreas was used as a positive control for the hormones 
insulin, C-Peptide, glucagon, and somatostatin (Fig 4.3.2). The transcription factor Ngn3 
was only detected at 16.5 days in mouse embryo (Fig 4.3.2), also as a positive control.  
Results                                                                                                     76 
 
 
Results                                                                                                     77 
 
Figure 4.3.1 Detection of pancreas-specific hormones and transcription factors in 
differentiated BMSC 
BMSC cultured for 3 days in presence of TSA and subsequent culturing for 7 days in presence of 
high glucose resulted in islet-like cultures. Immunostaining for pancreas-specific hormones in day 
10 islet-like clusters. (A) Double-immunofluorescence analysis revealed insulin (green), C-
peptide (red), and nuclear staining with DAPI (cyan); on merging both channels, the green 
(Insulin) and red (C-peptide) staining was seen as yellow. (B, C) Glucagon-positive cells (red) 
(B) and somatostatin-positive cells (red) (C) were present in the cultures (arrows). (D) Co-
staining of insulin (green) and somatostatin (red) was observed. (E) Transcription factor Ngn3 
was present in the nucleus of differentiated cells (arrow). (F-H) In the isotype control for rabbit 
IgG (Isotype 1; F) and goat IgG (Isotype 2; G) and in the negative control (no primary antibody; 
H), no immunostaining was observed; all were counterstained with DAPI (cyan) for nuclear 
staining. Scale bar 10 µm. 
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Figure 4.3.2 Specific hormone and transcription factor expression in mouse pancreas 
tissue 
Specific hormone and transcription factors expression in mouse pancreas tissue were analysed by 
immunofluorescence. (A) Double-immunofluorescence analysis revealed β-cells containing 
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insulin (green) and C-Peptide (red), with nuclei stained by DAPI (cyan); on merging of both 
channels, the green (insulin) and red (C-Peptide) staining appears yellow. (B, C) Glucagon-
positive (red) alpha cells at the periphery of an islet (arrow) (B) and somatostatin-secreting (red) 
delta cells also at the periphery of an islet (arrow) (C) in mouse pancreas. (D) Ngn3 antibody 
specific staining was present in the nuclei of 16.5-day mouse embryo pancreatic primordium 
(arrow). Scale bar 10 µm. 
 
4.4 Three-dimensional (3D) reconstruction image of islet like cell cluster 
Pancreatic β-cells synthesize insulin and store in secretory vesicles. Secretory vesicles are 
filled with insulin granules and C-Peptide, a by-product of insulin synthesis. Co-
localization of insulin and C-Peptide immunostaining confirms the synthesis of insulin in 
differentiated BMSC. An islet-like cluster, three-dimensional (3D) reconstruction image 
was created by using confocal microscopy. The islet-like cluster was stained with anti-
insulin (green) and anti-C-Peptide (red) antibodies. Various stacks were extracted from 
3D image.  The image shows perfect co-localization of insulin and C-Peptide (yellow 
colour) (Fig 4.4). Insulin and C-Peptide staining was granular, suggesting that insulin is 
located in secretory granules. Most of the insulin containing granules was situated near 
the periphery in the cytoplasm, without any background in the nucleus.  This result is in 
agreement with the notion that the in vitro differentiated BMSC produce insulin and store 
it in secretory vesicles.   
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Figure 4.4 Accumulation of insulin containing vesicles at the cell periphery 
Clusters of in vitro differentiated BMSC were stained with anti-insulin (green) and anti-C-Peptide 
(red) antibodies. The co-localization of insulin and C-Peptide (yellow dots) is appeared in the 
cytoplasm of islet like cell cluster. This image is visualized after extraction of different stacks of 
the 3D reconstruction image.   
 
4.5 Glucose regulated insulin secretion from differentiated BMSC 
 
In response to changes in the blood glucose concentrations insulin is released from 
pancreatic β-cells. To determine whether the differentiated BMSC were responsive to 
glucose concentrations, islet-like cells were exposed to different concentrations of 
glucose. Then insulin release upon exposure to high glucose was measured by using an 
ultra-sensitive mouse insulin ELISA. In order to enhance the sensitivity of these cells to 
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high-glucose challenge, the differentiated cells were switched to KRBH buffer containing 
0.5% BSA and 3.8 mM glucose and incubated for 3 hrs. Then the differentiated BMSC 
stimulated by the addition of 7 mM, 12 mM, or 27.7 mM glucose to the KRBH buffer for 
2 hrs in individual experiments. BM-derived islet-like cells after exposure to high glucose 
secreted insulin in a glucose-concentration-dependent manner (Fig 4.5.1). These data 
demonstrated that islet-like cell clusters derived from BM cells could secrete insulin in a 
glucose-regulated manner under the appropriate conditions as pancreatic β-cells. 
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Figure 4.5.1 Secretion of insulin upon high glucose challenge  
Differentiated BMSC were exposed to high glucose ELISA assay for insulin in Krebs Ringer 
Bicarbonate Hepes (KRBH) buffer removed from BM-derived islet-like clusters exposed to low 
(3.8 mM) and high glucose conditions (7 mM, 12 mM, and 27 mM) for 2 hrs.(omit to avoid 
repetition with text) Statistical significance was tested by Student‘s t test: * P< 0.05; **, P < 0.01; 
***, P< 0.001. 
 
Pancreatic β-cells synthesize and store insulin in the cytoplasm. BMSC treated for 3 days 
with TSA and BMSC differentiated in presence of TSA for 3 days and then additional 7 
days in high glucose medium were taken for analysis of intracellular insulin. Cell lysates 
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of day 3 culture and day 10 cultures were subjected to immunoprecipitation and Western 
blot analysis. Cell lysates of differentiated BMSC contained stored insulin, as the cell 
lysate of day 3 cultures contained an immunopositive band, and the band intensity 
increased in cell lysate at day 10 (Fig 4.5.2). Pancreatic tissue served as a positive 
control. In contrast, no corresponding band was detectable in untreated BMSC (Fig 
4.5.2). The data of insulin protein analysis therefore suggested that the differentiated 
islet-like clusters synthesized and stored insulin.  
 
 
 
Figure 4.5.2 Presence of intracellular insulin in differentiated BMSC  
BMSC were differentiated into islet-like clusters after treatment with TSA for 3 days and 
additional 7 days culturing in high glucose medium. The cell lysates of whole BMSC, 3 days 
culture, and 10 days culture were analysed for presence of intracellular insulin. Lane 1: Whole 
BM. Lane 2: Day 3 culture. Lane 3: Day 10 culture. Lane 4: Adult mouse pancreas (control). 
 
4.6 Endocrine-specific gene expression in differentiated islet-like clusters 
Pancreatic development and gene expression are regulated by specialized transcription 
factors. To determine whether endocrine-specific transcription factors and pancreas-
specific genes were expressed during the differentiation into islet-like clusters, RT-PCR 
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analysis was performed at various time points during the culture of BM cells under high 
glucose conditions following TSA treatment. Transcripts for PDX-1, Pax4, Hnf3β, and 
Isl 1 were not detectable in undifferentiated BM cells; in contrast, they were up-regulated 
in differentiated cells (Fig 3.5). PDX1 and Hnf3β transcripts were expressed on day 3 
after TSA treatment and increased by day 10. The PCR product of Ngn3 was visible in 
both undifferentiated and differentiated BM cells. PCR products for insulin genes I and II 
were visible at day 3 and day 10. In contrast, transcripts of other major islet-specific 
hormones, such as IAPP, glucagon, and somatostatin, were not detected on day 3 of 
differentiation and were expressed only on day 10. PCR products for the ATP-sensitive 
potassium (KATP) channel-specific sulfonylurea receptor (SUR-1) and glucose 
transporter gene (GLUT-2) were detectable only at day 10. Gene expression analysis in 
BM-derived islet-like clusters was similar to that in the native pancreas tissue and 
confirmed the differentiation of BM cells into islet-like cells in vitro upon treatment with 
TSA and subsequent culturing in high glucose. 
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Figure 4.6 Endocrine-specific gene expression in differentiated islet-like clusters 
BMSC differentiated into islet-like clusters after culturing in presence of TSA and high glucose 
medium. Total RNA isolated from whole bone marrow, day 3 culture, day 10 culture, adult 
mouse pancreas was subjected to RT-PCR analysis with primers for the indicated genes (listed 
right). BM: Undifferentiated whole BM. D3: Day 3 culture with TSA only. D10: Day 10 culture 
with high glucose and GLP-1. Pancreas: Adult mouse pancreas (positive control). Lane 5: No 
template (negative control). 
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4.7 Ultrastructural analysis of insulin-producing cell clusters 
Ultrastructural analysis of BM-derived insulin-producing clusters was also performed. 
Differentiated cells at low magnification revealed structures typical of a secretory cell, 
with secretory vesicles containing dense granules (Fig 4.7A). Immunogold electron 
microscopy showed insulin within the small secretary vesicles of the insulin-producing 
clusters (Fig 4.7B). Gold-labeling also detected faint globular structures of differing size 
filled with a low-density material. Positive and negative controls for immunogold 
labeling are presented in Fig 4.7C and Fig 4.7D, respectively. Adult pancreatic β-cells 
showed several positive immunogold particles per secretory granule (Fig 4.7C). The 
pancreatic β-cells were examined only to validate the assay and not to correlate insulin-
positive signals between the β-cells and the BM-derived insulin-producing clusters. 
Control BM cells showed no specific labelling, but a few non-specific particles were seen 
in the cytoplasm (Fig 4.7D). Thus, the differentiated BM cells exhibited features typical 
of an adult β-cell, and insulin granules were observed within the secretory vesicles 
suggesting that these cells had differentiated into pancreatic β-like cells capable of 
synthesizing insulin.  
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Figure 4.7 Presence of insulin granules in secretory vesicles 
Differentiated BMSC were analysed for presence of insulin granules after post-embedding 
immunogold staining for insulin in day 10 islet-like clusters. (A) Secretory granules (arrow) are 
densely packed within the cytoplasm of the differentiated cell. (B) At higher magnification, 
insulin granules (arrows) are seen in secretory vesicles (black dots represent immunogold labeled 
insulin). (C) Positive control for immunogold labeling: positive granules (arrows) in adult mouse 
pancreas. (D) Negative control. Only non-specific staining is observed. Scale bar: (A) and (B) 0.5 
µm, (C) 1 µm and (D) 0.5 µm. 
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4.8 Chromatin morphology after treatment with TSA 
The chromatin morphology was studied before and after treatment of TSA. The 
chromatin accessibility changes following histone acetylation. Nuclei of control BM cells 
were seen as dense chromatin areas as brighter spots around the nucleolus and close to 
the nuclear membrane (day “0” Figure 4.8). After TSA treatment chromatin distribution 
was more homogeneous and most of dense chromatin disappeared (day “1” Figure 4.8).   
The chromatin decondensation attributable to acetylation is however reversible. These 
effects were well demonstrated in cultures of BM cells treated with TSA for three days, 
showed few cells with dense chromatin (day “3” TSA treated cell nucleus Figure 4.8), but 
majority of the cells chromatin still remain homogeneous.  After a wash-out step all cells 
regained dense chromatin (day “5”, day “10” Figure 4.8). Regular condensed chromatin 
was visualized in all TSA untreated cells.   
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Figure 4.8 TSA-induced changes of interphase chromatin morphology.  
Chromatin distribution in undifferentiated BMSC, after treatment with TSA and after 
differentiation into islet-like cells was analyzed. Nuclei of control cells contain dense chromatin 
areas, seen as brighter spots around the nucleolus and close to the nuclear membrane (day 0). 
TSA-treated cells exhibit a more homogeneous chromatin distribution, and most of the dense 
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chromatin disappears (day 1, day 3). The effect of TSA is reversible, since dense chromatin 
regions reappear after TSA is washed out (day 5, day 10 nuclei).  The cells shown here were fixed 
and DAPI-stained to reveal the nuclei. Magnification 63x. (In collaboration with Dr. Karsten 
Rippe, Heidelberg). 
 
4.9 Genes expressed at different time points of differentiation 
The expression of genes at different time points during culture was analyzed by using 
microarray analysis. BM cells as a control and day 3 cultures and day 10 cultures after 
differentiation into islet-like clusters were taken for analysis. Control versus day 3 
cultures revealed that 8964 additional genes were expressed, whereas control versus day 
10 cultures showed the expression of 1076 additional genes. A comparison of day 10 
with day 3 cultures demonstrated that an additional 160 genes were expressed in the older 
culture (Fig 3.8). These results indicated that BM cells that had been stimulated to 
differentiate into islet-like cells initially increased the numbers of genes that they 
expressed, although the number of active genes declined at later culture times.  
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Figure 4.9 Analysis of genes expressed at various time points.  
Control BM cells (CTR_1) versus cultures at day 3 (d3) and at day 10 (d10). Expressed genes 
were analyzed by microarray analysis. When BM cells were compared with to day 10 cultures, an 
additional1076 genes were expressed (pink circle), whereas in the comparison of day 10 versus 
day 3 cultures, 160 additional genes were expressed (blue circle). A comparison of control BM 
cells versus the day 3 culture showed that 8964 additional genes were expressed. 
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5. Discussion 
 
5.1 Chromatin remodeling factors induce differentiation of BMSC 
Adult stem cells could potentially provide an abundant and ethically acceptable source of 
islet cells for transplantation therapies. Methods for stem cell differentiation must involve 
the activation of genes that are inactive, at least in part, because they lie in silent 
chromatin neighborhoods. Therefore chromatin reprogramming can contribute to the in 
vitro differentiation of BMSC into insulin-producing cells were evaluated chromatin-
remodeling agents if they could stimulate BMSC differentiation. TSA, azacytidine, 
butyrate, and DMSO are well-known chromatin-remodeling agents. BMSC were cultured 
in the presence of azacytidine, butyrate, or DMSO in individual cultures for 3 days, and 
after an additional 7 days in high glucose medium, we obtained low numbers of cellular 
aggregates. The three-dimensional cellular morphology of the cell aggregates closely 
resembled islet-like clusters.  Sodium butyrate treatment resulted in a small numbers of 
islet-like clusters. Azacytidine was cytotoxic at higher concentrations but, at micromolar 
concentrations, exerted an effect on BMSC resulting in the formation of islet-like cells. 
DMSO treatment and high glucose medium also resulted in islet-like clusters.  
The organ specificity of these clusters resulting from sodium butyrate, azacytidine, or 
DMSO treatment followed by culture in high glucose medium was confirmed by RT-
PCR analysis by expression ed pancreatic β-cell-specific genes, and the transcription 
factors necessary for development. The islet-like clusters expressed insulin gene I and II, 
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somatostatin, and the transcription factors Pax 4, HNF 3 beta, and Isl 1. The gene 
analysis showed that islet-like clusters resulting from the treatment of chromatin 
remodeling factors and high glucose medium expressed pancreas-specific genes. These 
results further suggested that sodium butyrate, azacytidine, or DMSO treatment leads to 
the differentiation of BMSC into a pancreatic β-cell-like population, but with low 
efficacy. Therefore culture conditions were established that allowed differentiation of 
BMSC into insulin. And there is a necessity to standardize the type and concentration of 
compounds with respect to the treatment and length of exposure and with regard to the 
subsequent culturing in high glucose and GLP-1-containing media.   
BMSC that were treated with the histone deacetylase inhibitor (HDACi), TSA, for three 
days and subsequently cultured in high glucose medium (25mM) containing 10 nm GLP-
1 produced large numbers of islet-like cell clusters. After 3 days of treatment with TSA, 
BMSC remain quiescent, without any multiplication. However, removal of TSA from the 
medium and exposure to high glucose conditions immediately resulted in the formation 
of cellular aggregates. Culturing BMSC for additional 7 days in high glucose medium 
increased the size and number of the cellular aggregates. Once these aggregates had 
achieved their maximum size in a time period of 10 days, no further growth occurred, and 
they remained static.  The morphology of the cellular aggregates was similar to that of 
pancreatic islets, as previously reported. Islet-like clusters derived from BMSC appeared 
to contain clear margins. In contrast, BMSC cultured for 10 days in normal DMEM with 
10% FBS showed normal morphology without any significant changes. These results thus 
demonstrated that BMSC treated with the HDACi, TSA, and cultured in high glucose 
medium differentiated into islet-like clusters. Further, BMSC treated with TSA and 
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subsequently cultured in the presence of high glucose showed a higher number and larger 
size of three-dimensional spheroid clusters in comparison with those seen after treatment 
with other chromatin remodeling agents. In this way concentration and incubation period 
were optimized and TSA was found to be optimal differentiation agent, therefore, all 
further work was carried out with TSA.  
5.2 Detection of insulin-producing cells in the culture  
 
BMSC treated with TSA and subsequently cultured in the presence of GLP-1 and high 
glucose medium produced islet-like clusters. To evaluate presence of insulin-producing 
cells  in the culture, the cells were stained with Dithizone (DTZ) and Newport Green 
(NG-Ac), as pancreatic β-cells contain large amounts of zinc used in the synthesis, 
storage, and secretion of insulin.  
DTZ is a zinc-binding substance, and pancreatic islets from animal species such as 
mouse, dog, pig, and human are known to be stained crimson red by its treatment, 
because of their higher zinc content compared with that of other tissues. DTZ staining is a 
simple and quick method specifically to identify insulin-producing cells from a mixed 
cell culture preparation of differentiated BMSC. Individual differentiated BMSC cells, 
specifically cells in the islet-like clusters, exhibited prominent crimson red staining upon 
staining with DTZ solution. In particular, cells present in the core of islet-like clusters 
stained crimson red; this is similar to the location of the position of pancreatic β-cells in 
the islets of Langerhans in which β-cells are present in the core surrounded by the mantle 
of other pancreatic hormone-producing cells. BMSC cultured for 10 days in normal 
medium showed no significant staining, whereas islet-like cells stained crimson red for 
DTZ indicating the presence of zinc-containing cells in the culture. 
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Newport Green (NG-Ac) is a zinc fluorescent probe; the loading of the esterified form of 
NG-Ac is reported to be easy, rapid, specific, and nontoxic to insulin-producing cells. 
NG-Ac produces fluorescence upon binding with zinc; therefore it is useful for the 
purification and collection of insulin-producing cells. The examination of the distribution 
NG-Ac inside the differentiated BMSC by confocal microscopy highlighted intense NG 
fluorescence mainly associated with secretory granules, possibly demonstrating that NG 
was competing with insulin for zinc inside these granules. Staining of individual cells 
revealed a heterogeneous intensity of fluorescence with cytoplasmic dots. 
Positive cells for NG-Ac and DTZ staining thus demonstrated that insulin-producing cells 
were present in the differentiated BMSC culture. The use of NG-AC may be helpful for 
the purification and sorting of insulin-producing cells from in vitro differentiated BMSC 
for further use of these cells in vivo. These results strengthen the view that the in vitro 
differentiated cells in the islet-like cluster produce insulin.   
 
5.3 Presence of transcription factors and genes specific for pancreas  
To further characterize the islet-like cells derived from BMSC after treatment with TSA 
and high glucose, we analyzed the gene expression of a variety of endocrine pancreatic 
markers and transcription factors involved in the development of pancreas by using RT-
PCR analysis. The differentiated cells expressed mRNA of the endoderm-specific and 
pancreas-specific transcription factor genes, HNF3 beta and pancreatic duodenal 
homeobox 1 (PDX1), respectively, and of the genes for insulin I, insulin II, glucagon, PP, 
and GLUT 2. The transcription factor, PDX1 expressed during day 3 of culture may have 
initiated a cascade of events leading to insulin transcription. High levels of PDX 1 
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transcript were found at day 10. Pax 4 transcripts were up-regulated at day 10; in vivo 
Pax 4 is essential for proper β-cell development, and its expression is restricted to 
endocrine progenitor cells. The neurogenin 3 (NGN3) transcript was highly expressed 
from the beginning; transcription factor NGN3 is involved in the proliferation and 
specification of early endocrine progenitors. GLUT 2 is a highly specific pancreatic β-
cell or islet gene and plays an important role in glucose-stimulated insulin secretion. 
GLUT 2 expression was found in day 10 differentiated islet-like clusters. Transcript for 
the component of K+ ATP channel, SUR 1, was also detected. Transcription factor Isl-1, 
which controls cell-fate decisions required for the differentiation of islet cells is 
expressed during BMSC differentiation. Further evidence for the activation of a 
pancreatic differentiation program in BMSC on following our protocol is the up-
regulation of IAPP, a peptide almost exclusively expressed in β-cells and co-secreted 
with insulin.  The transcripts of the major pancreas-specific hormones insulin I and 
insulin II, glucagon, somatostatin, and PP were also present in our cultures. The glucagon 
was gene expressed only at low levels; this correlates with the immunofluorescence 
analysis showing that only a few cells were positive for glucagon. This gene expression 
pattern was similar to that of mouse pancreas tissue. The analysis by RT-PCR thus 
demonstrated that, using TSA and high glucose culture conditions during differentiation 
increased the expression of pancreatic genes.   Therefore, BMSC differentiated islet-like 
cells are similar to pancreatic endocrine cell population.   Whole bone marrow, day 3 
culture after TSA treatment and day 10 culture after high glucose and Glp-1 treatment 
were analyzed by microarray.  Microarray analysis showed that a wide variety of genes 
were induced upon treatment of BMSC with TSA. The initial increase in up-regulated 
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genes was significant, i.e., 8964 genes from whole bone marrow in day 3 cultures after 
TSA treatment. However, there was not much difference after removal of TSA, from day 
3 cultures to day 10 cultures in the presence of high glucose and GLP-1. One explanation 
is that other factors might now be controlling the expression of the genes: the 
differentiation of the BM cells into islet-like cells is complete, and now only the 
housekeeping genes and the specific genes involved with insulin production are 
functional. However, further work is required to clear up this point. 
 
5.4 Expression of pancreas-specific hormones in differentiated cells  
Endocrine pancreas contains alpha cells, beta cells, delta cells and PP-secreting cells, 
which secrete the major hormones glucagon, insulin, and somatostatin and PP, 
respectively. Insulin and glucagon are major hormones that regulate the level of glucose 
in the blood. Whether the differentiated BMSC contained these hormone-producing cells 
was investigated by means of immunocytochemistry. 
The most essential feature of the in vitro differentiated BMSC is insulin production. To 
prove that insulin present in differentiated BMSC stems from intracellular synthesis co-
expression of insulin and C-Peptide was analyzed.  It is necessary to confirm whether the 
cells synthesize the insulin or only absorbed insulin from the medium. C-Peptide is a by-
product of insulin synthesis, and therefore the demonstration of C-Peptide and the co-
localization of insulin are reliable methods for investigating pancreatic differentiation in 
vitro. The formation of C-Peptide demonstrates de novo insulin production and excludes 
those cells that only concentrate insulin from the medium. A high fraction of insulin-
positive cells in islet-like cells co-expressed C-Peptide and were organized in islet-like 
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clusters. Co-expression of insulin and C-Peptide in most of the BMSC-derived cells 
indicated de novo insulin synthesis and ruled out the idea that the cells took insulin up 
from the culture medium.    
In addition to insulin-producing cells, some somatostatin-positive and glucagon-positive 
cells were present in culture. Analysis by single-staining immunocytochemistry showed 
that in contrast to the large number of insulin-positive cells fewer glucagon and 
somatostatin positive cells were also present in culture. Double-immunostaining for 
insulin and somatostatin confirmed the presence of a minor fraction of somatostatin-
containing cells. These results are in agreement with endocrine pancreatic tissue, viz., 60-
80% beta cells (insulin secreting) and only 3-10% delta cells (somatostatin secreting). 
The presence of cells positive for insulin, glucagon, and somatostatin cells confirmed the 
presence of endocrine pancreas specific beta, alpha and delta like cells in our culture 
system, similar to cells in pancreas various cell types result from in vitro differentiation 
conditions.  
 The expression of transcription factor PDX 1, which is necessary for early pancreatic 
development, was also analyzed in the islet-like cells. Although, at later stages, high 
levels of the PDX 1 gene transcript are found, we have failed to detect PDX 1 by 
immunocytochemistry. This is not surprising because, as shown previously, even when 
the mRNA for PDX 1 is highly abundant, immunoreactivity can hardly be detected 
(Stoffers et al., 1999). 
During embryogenesis, only those cells expressing transcription factor Ngn3 are islet 
progenitors (Gu et al., 2002). Indeed, we have revealed the expression of the Ngn3 
exclusively in the nucleus of our islet-like cells. Other reports (Chiang et al., 2003) have 
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shown that precursor cells co-expressing glucagon, insulin, and Ngn3 eventually become 
mature β-cells. The islet-like clusters in our culture system express insulin, glucagon, and 
Ngn3 and thus resemble pancreatic precursor cells with respect to these parameters.  
We have compared the immunohistochemical staining of adult mouse pancreas with that 
of our islet-like cells. Insulin and C-peptide staining in murine adult pancreas was similar 
to that in the clusters of islet-like cells, whereas the somatostatin- and glucagon-positive 
cells formed the mantle of the islets of Langerhans. The 16.5-day embryo was used as a 
positive control for transcription factor NGN-3 as it is not expressed in adult pancreas 
tissue. As a whole, the immunohistochemical staining pattern of BMSC-derived islet-like 
cells was similar in nature to that of the islets of Langerhans and endocrine specific cells 
were present in the differentiated BMSC.     
Co-expression of insulin and C-Peptide showed the de novo synthesis of insulin by islet-
like clusters.  Three-dimensional (3D) reconstruction images were created for islet-like 
clusters stained with anti-insulin antibody and anti-C-Peptide antibody, by using confocal 
microscopy. The images showed the perfect co-localization of insulin and C-Peptide. 
Further, insulin and C-Peptide staining was granular, suggesting a location in secretory 
granules. Most of the insulin-containing granules were situated near the periphery in the 
cytoplasm, without any background in the nucleus. 3D reconstruction images thus 
confirmed the co-localization of insulin and C-Peptide in the differentiated islet-like cells. 
These cells were full of insulin-containing granules situated near the cell periphery and so 
could be considered as mature and able to secrete insulin upon high glucose induction.  
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5.5 Regulation of insulin secretion in differentiated islet-like cells  
A fundamental property of pancreatic β-cells is to regulate the secretion of insulin in 
response to   glucose levels. BMSC cultured in presence of TSA for 3 days and 
subsequently cultured in a high glucose medium with 10 nm GLP-1 formed islet-like 
clusters. Glucose-regulated insulin release was analyzed, by means of ELISA, in the 
differentiated islet-like cells in vitro by exposing the islet-like cells to high glucose. The 
islet-like cells, after stimulation with high glucose, secreted significant amounts of 
insulin. The different concentrations of glucose therefore induced insulin release in a 
glucose-dependent manner. Although this secretion of insulin seems to be dependent 
upon the concentration of glucose in the medium, osmotic effects cannot be ruled out, as 
the insulin secretion was measured at supra physiological conditions. However, 
Lumelsky et al., (2001) have previously found no such effects with sucrose. In contrast, 
control BMSC cultured in normal medium showed no significant release of insulin in the 
presence or absence of glucose challenge. These data suggest that high glucose culture 
plays an indispensable role in the differentiation of BMSC into insulin-producing cells, 
and that differentiated BMSC are responsive to glucose challenge. GLP-1 is also known 
to stimulate insulin secretion. Therefore culture conditions; high glucose and GLP-1 are 
necessary for differentiation of BMSC into functional insulin-secreting cells.  In the 
present study, we have thus successfully demonstrated the secretion of insulin from 
BMSC-derived islet-like cells by using ELISA. 
The differentiated BMSC or islet-like cells synthesize and store detectable amounts of 
insulin, as determined by immunoprecipitation and Western blot analysis. We have found 
that the cell lysates of cells cultured for 3 days in the presence of TSA and differentiated 
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islet-like clusters cultured for 10 days (3 days in the presence of TSA + 7 days in high 
glucose and GLP-1) contained significant amount of insulin. This correlates with the 
gene expression data, the insulin gene being up-regulated after 3 days of TSA treatment 
and in differentiated islet-like cells cultured for 10 days. However, BMSC cultured in 
normal medium alone show no insulin reactivity. These results suggest that the BMSC-
derived islet-like cells store insulin and regulate secretion of insulin in response to 
glucose challenge.   
 
5.6 Presence of insulin in secretory vesicles of differentiated BMSC 
Pancreatic β-cells synthesize and store insulin in secretory vesicles; upon high glucose 
induction, this insulin is secreted into the blood. Ultrastructural analysis of BMSC-
derived insulin-producing clusters was performed to locate the insulin inside the cells. 
Electron microscopy of differentiated BMSC at low magnification revealed structures 
typical of secretory cells, with secretory vesicles containing dense granules. Immunogold 
electron microscopy further showed insulin within the small secretary vesicles of the 
insulin-producing clusters. Gold-labeling also detected faint globular structures of 
differing size filled with a low-density material, and granules with an electron-dense core 
at the apical pole of the islet-like cells. In comparison, adult pancreatic β-cells also 
exhibited several positive immunogold particles per secretory granule. Control BMSC 
cultured in normal DMEM possessed a few non-specific particles in the cytoplasm but no 
specific labeling. Therefore differentiated BMSC thus exhibited features typical of an 
adult β-cell, and insulin granules were observed within the secretory vesicles suggesting 
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that these cells are capable of synthesizing and storing insulin similar to pancreatic β-
cells.   
 
5.7 Effect of TSA treatment on cells 
The higher order chromatin structure represents an important and general regulatory 
mechanism for gene expression. It can be classified into two cytologically distinct 
confirmations: relatively uncondensed euchromatin and much denser heterochromatin. 
Heterochromatin is transcriptionally less active than euchromatin. TSA induces a more 
“open” chromatin state in response to histone acetylation and increases the accessibility 
of transcription complexes to genomic DNA (Gorisch et al., 2005).  
The chromatin accessibility changes following TSA treatement were visualized. Nuclei 
of untreated BM cells were seen to contain dense chromatin areas as brighter spots 
around the nucleolus and close to the nuclear membrane. However, few cells showed a 
homogeneous morphology, suggesting that these cells could be stem cells present in the 
BM (day “0” Figure 4.8). The chromatin distribution of TSA-treated cells was more 
homogeneous. The chromatin decondensation attributable to acetylation was however 
reversible. These effects were well demonstrated in cultures of BM cells treated with 
TSA for 3 days, which contained only a few cells with dense chromatin.  After removal 
of TSA from the culture medium, all cells regained dense chromatin.   
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5.8 Out look 
We have explored the possibility of using mouse BM cells as a source for insulin-
producing cells following treatment with TSA and subsequent culturing in the presence 
of high glucose and GLP-1. GLP-1 is capable of converting intestinal epithelial cells into 
functional insulin-producing cells. We have generated functional insulin-producing cells 
from BM cells and have confirmed the occurrence of insulin production by RT-PCR, 
immunofluorescence, Western blot, and electron microscopy combined with immunogold 
anti-insulin labeling. Furthermore, the functionality of the insulin-producing cells 
generated in vitro from BMSC has been tested by measuring insulin release in response 
to high glucose concentrations. Taken collectively, these studies provide evidence that 
the BM contains pluripotent cells capable of being reprogrammed in vitro by TSA to 
become functional insulin-producing cells.   
Here, we showed that bone-marrow-derived can generate pancreatic β-like cells, and that 
they secrete insulin in a glucose-dependent manner. Diabetes is a leading cause of 
morbidity and mortality in industrialized countries today. The use of bone marrow as a 
source of pancreatic cell progenitors has the potential for ex vivo expansion, 
differentiation, and autologous transplantation. Thus, immunosuppression to prevent 
rejection could be avoided, and further, these cells should not become malignant. The 
identification of the subpopulation in the bone marrow that gives rise to functional 
insulin-secreting cells, the mechanism of islet engraftment, and the environmental signals 
that trigger differentiation will be essential for exploiting these cells for the treatment of 
type 1 and possibly some forms of type 2 diabetes. However, further research has to be 
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carried out on chromatin remodeling factors in order to be able to understand the 
mechanisms that are involved in cell-fate determination. The islet-like cells that have 
been produced here might provide a suitable model for such research. 
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